{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## BlackSheep Cookbook Exploration\n",
    "\n",
    "The Black Sheep Analysis allows researchers to find trends in abnormal protein enrichment among patients in CPTAC datasets. In this Cookbook, we will go through the steps needed to perform a full Black Sheep Analysis."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Step 1a: Import Dependencies\n",
    "First, import the necessary dependencies and load cptac data."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "import numpy as np\n",
    "import pandas as pd\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "import cptac\n",
    "import binarization_functions as bf\n",
    "import blackSheepCPTACmoduleCopy as blsh\n",
    "import gseapy as gp\n",
    "from gseapy.plot import barplot, heatmap, dotplot\n",
    "import requests\n",
    "import json"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Step 1b: Load Data and Choose Omics Table\n",
    "For this analysis, we will be looking at results across the proteomics, transcriptomics, and phosphoproteomics tables."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Insufficient internet. Check your internet connection.\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "False"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "cptac.download(dataset='endometrial')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "                                    \r"
     ]
    }
   ],
   "source": [
    "en = cptac.Endometrial()\n",
    "proteomics = en.get_proteomics()\n",
    "transcriptomics = en.get_transcriptomics()\n",
    "clinical = en.get_clinical()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "#Append Genomics_subtype and MSI_status to clinical table\n",
    "df= en.get_derived_molecular()\n",
    "clinical['MSI_status'] = df['MSI_status']\n",
    "clinical['Genomics_subtype'] = df['Genomics_subtype']"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Step 2: Determine what attributes you would like to A/B test. \n",
    "For this analysis, we will iteratively go through the various columns in the clinical dataset, to determine if any of them have trends within them for protein enrichment."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "#Create a copy of the original Clinical DataFrame and drop irrelevant columns.\n",
    "annotations = pd.DataFrame(clinical.copy())\n",
    "annotations = annotations.drop(['Patient_ID', \n",
    "                                'Treatment_naive', \n",
    "                                'Tumor_purity', \n",
    "                                'Gender', \n",
    "                                'Tumor_Site_Other'], axis=1)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Step 2a: Binarize column values"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "tumor_map = {'Tumor':'Normal_Tumor', \n",
    "             'Adjacent_normal':'Other_tumor', \n",
    "             'Enriched_normal':'Other_tumor', \n",
    "             'Myometrium_normal':'Other_tumor'}\n",
    "\n",
    "annotations['Proteomics_Tumor_Normal'] = bf.binarizeCategorical(clinical, \n",
    "                                                                'Proteomics_Tumor_Normal', \n",
    "                                                                tumor_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "country_map = {'United States':'US', \n",
    "               'Ukraine':'Other', \n",
    "               'Other_specify':'Other', \n",
    "               'Poland':'Other'}\n",
    "\n",
    "annotations['Country'] = bf.binarizeCategorical(clinical, \n",
    "                                                'Country', \n",
    "                                                country_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "annotations['BMI'] = bf.binarizeRange(clinical, 'BMI', 18, 25, \n",
    "                                      'Healthy', 'Unhealthy')\n",
    "\n",
    "annotations['Age'] = bf.binarizeCutOff(clinical, 'Age', \n",
    "                                       60.0, 'Old', 'Young')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "FIGO_map = {'FIGO grade 1':'Low_grade', \n",
    "            'FIGO grade 2':'High_grade', \n",
    "            'FIGO grade 3':'High_grade'}\n",
    "\n",
    "annotations['Histologic_Grade_FIGO'] = bf.binarizeCategorical(clinical, \n",
    "                                                              'Histologic_Grade_FIGO', \n",
    "                                                              FIGO_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "Myo_map = {'under 50 %':'under_50%', \n",
    "           '50 % or more': '50%_or_more', \n",
    "           'Not identified': 'under_50%'}\n",
    "\n",
    "annotations['Myometrial_invasion_Specify'] = bf.binarizeCategorical(clinical, \n",
    "                                                                    'Myometrial_invasion_Specify', \n",
    "                                                                    Myo_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "path_tumor_map = {'pT1a (FIGO IA)':'Not_FIGO_III', \n",
    "            'pT1b (FIGO IB)':'Not_FIGO_III', \n",
    "            'pT2 (FIGO II)':'Not_FIGO_III', \n",
    "            'pT1 (FIGO I)':'Not_FIGO_III', \n",
    "            'pT3a (FIGO IIIA)':'FIGO_III', \n",
    "            'pT3b (FIGO IIIB)':'FIGO_III'}\n",
    "\n",
    "annotations['Path_Stage_Primary_Tumor-pT'] = bf.binarizeCategorical(clinical, \n",
    "                                                                    'Path_Stage_Primary_Tumor-pT', \n",
    "                                                                    path_tumor_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "path_lymph_map = {'pN0':'Not_FIGO_III', \n",
    "                  'pNX':'Not_FIGO_III', \n",
    "                  'pN1 (FIGO IIIC1)':'FIGO_III', \n",
    "                  'pN2 (FIGO IIIC2)':'FIGO_III'}\n",
    "\n",
    "annotations['Path_Stage_Reg_Lymph_Nodes-pN'] = bf.binarizeCategorical(clinical, \n",
    "                                                                      'Path_Stage_Reg_Lymph_Nodes-pN', \n",
    "                                                                      path_lymph_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "clin_stage_map = {'cM0':'cM0_or_cM1', \n",
    "                  'cM1':'cM0_or_cM1', \n",
    "                  'Staging Incomplete':'Staging_Incomplete'}\n",
    "\n",
    "annotations['Clin_Stage_Dist_Mets-cM'] = bf.binarizeCategorical(clinical, \n",
    "                                                                'Clin_Stage_Dist_Mets-cM', \n",
    "                                                                clin_stage_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "path_stage_map = {'Staging Incomplete': 'No_distant_metastasis', \n",
    "                  'No pathologic evidence of distant metastasis':'No_distant_metastasis', \n",
    "                  'pM1':'Distant_Metastasis'}\n",
    "\n",
    "annotations['Path_Stage_Dist_Mets-pM'] = bf.binarizeCategorical(clinical, \n",
    "                                                                'Path_Stage_Dist_Mets-pM', \n",
    "                                                                path_stage_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "tumor_stage_map = {'Stage I':'Stage_I_or_II', \n",
    "                   'Stage II':'Stage_I_or_II', \n",
    "                   'Stage III':'Stage_III_or_IV', \n",
    "                   'Stage IV':'Stage_III_or_IV'}\n",
    "\n",
    "annotations['tumor_Stage-Pathological'] = bf.binarizeCategorical(clinical, \n",
    "                                                               'tumor_Stage-Pathological', \n",
    "                                                               tumor_stage_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "FIGO_stage_map = {'IA':'I_or_II', \n",
    "                  'IB':'I_or_II', \n",
    "                  'II':'I_or_II', \n",
    "                  'IIIA':'III_or_IV', \n",
    "                  'IIIC1':'III_or_IV', \n",
    "                  'IVB':'III_or_IV', \n",
    "                  'IIIC2':'III_or_IV', \n",
    "                  'IIIB':'III_or_IV'}\n",
    "\n",
    "annotations['FIGO_stage'] = bf.binarizeCategorical(clinical, \n",
    "                                                   'FIGO_stage', \n",
    "                                                   FIGO_stage_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "diabetes_map = {'No':'No', \n",
    "                'Yes':'Yes', \n",
    "                'Unknown':'No'}\n",
    "\n",
    "annotations['Diabetes'] = bf.binarizeCategorical(clinical, \n",
    "                                                 'Diabetes', \n",
    "                                                 diabetes_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "race_map = {'White':'White', \n",
    "            'Black or African American':'Not_White', \n",
    "            'Asian':'Not_White', \n",
    "            'Not Reported':'Not_White'}\n",
    "\n",
    "annotations['Race'] = bf.binarizeCategorical(clinical, \n",
    "                                             'Race', \n",
    "                                             race_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "ethnicity_map = {'Not-Hispanic or Latino':'Not_Hispanic', \n",
    "                 'Not reported':'Not_Hispanic', \n",
    "                 'Hispanic or Latino':'Hispanic'}\n",
    "\n",
    "annotations['Ethnicity'] = bf.binarizeCategorical(clinical, \n",
    "                                                  'Ethnicity', \n",
    "                                                  ethnicity_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "tumor_site_map = {'Other, specify':'Not_Anterior', \n",
    "                  'Anterior endometrium':'Anterior', \n",
    "                  'Posterior endometrium':'Not_Anterior'}\n",
    "\n",
    "annotations['Tumor_Site'] = bf.binarizeCategorical(clinical, \n",
    "                                                   'Tumor_Site', \n",
    "                                                   tumor_site_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "annotations['Tumor_Size_cm'] = bf.binarizeCutOff(clinical, \n",
    "                                                'Tumor_Size_cm', 4.0, \n",
    "                                                'Large_tumor', \n",
    "                                                'Small_tumor')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "num_pregnancies_map = {2:'Less_than_3', \n",
    "                       1:'Less_than_3', \n",
    "                       'None':'Less_than_3', \n",
    "                       None:'Less_than_3', \n",
    "                       3:'3_or_more', \n",
    "                       '4 or more':'3_or_more'}\n",
    "\n",
    "annotations['Num_full_term_pregnancies'] = bf.binarizeCategorical(clinical, \n",
    "                                                                  'Num_full_term_pregnancies', \n",
    "                                                                  num_pregnancies_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "genomics_map = {'MSI-H':'MSI-H', \n",
    "                'CNV_low':'Other_subtype', \n",
    "                'CNV_high':'Other_subtype', \n",
    "                'POLE':'Other_subtype'}\n",
    "\n",
    "annotations['Genomics_subtype'] = bf.binarizeCategorical(clinical, \n",
    "                                                         'Genomics_subtype', \n",
    "                                                         genomics_map)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Step 3: Perform outliers analysis"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\Daniel\\AppData\\Local\\conda\\conda\\envs\\Research\\lib\\site-packages\\numpy\\lib\\nanfunctions.py:1391: RuntimeWarning: All-NaN slice encountered\n",
      "  overwrite_input, interpolation)\n"
     ]
    }
   ],
   "source": [
    "outliers_prot = blsh.make_outliers_table(proteomics, iqrs=1.5, \n",
    "                                         up_or_down='up', \n",
    "                                         aggregate=False, \n",
    "                                         frac_table=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "metadata": {},
   "outputs": [],
   "source": [
    "length = int(len(outliers_prot.index) / 2)\n",
    "only_outliers_up_prot = outliers_prot[:length]\n",
    "outlier_up_prot_dict = {}\n",
    "for i in range(length):\n",
    "    key = proteomics.index[i]\n",
    "    my_filter = only_outliers_up_prot.iloc[i] == 1.0\n",
    "    value = list(only_outliers_up_prot.iloc[i][my_filter].index)\n",
    "    outlier_up_prot_dict[key] = value"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Step 4: Wrap your A/B test into the outliers analysis, and create a table"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "results_prot = blsh.compare_groups_outliers(outliers_prot, \n",
    "                                            annotations)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Many of the output values from compare_group_outliers are NaN, so here we will get rid of the NaN values for visualization purposes."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "results_prot = results_prot.dropna(axis=0, how='all')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "sig_cols = []\n",
    "for col in results_prot.columns:\n",
    "    sig_col = bf.significantEnrichments(results_prot, col, 0.01)\n",
    "    if sig_col is not None and len(sig_col) > 5:\n",
    "        sig_cols.append(sig_col)\n",
    "    else:\n",
    "        results_prot = results_prot.drop(col, axis=1)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Step 5: Visualize these enrichments"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\Daniel\\AppData\\Local\\conda\\conda\\envs\\Research\\lib\\site-packages\\ipykernel_launcher.py:1: MatplotlibDeprecationWarning: Adding an axes using the same arguments as a previous axes currently reuses the earlier instance.  In a future version, a new instance will always be created and returned.  Meanwhile, this warning can be suppressed, and the future behavior ensured, by passing a unique label to each axes instance.\n",
      "  \"\"\"Entry point for launching an IPython kernel.\n"
     ]
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAcMAAAM/CAYAAACtSbmVAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\nWngWQ0nSwrMYSpIWnsVQkrTw/g/9YKjjq6OrvgAAAABJRU5ErkJggg==\n",
      "text/plain": [
       "<Figure size 468x432 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "axis = plt.axes()\n",
    "sns.heatmap(results_prot, ax = axis)\n",
    "axis.set_title(\"Significantly Up-Regulated Genes in Endometrial Cancer Tumors\")\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Step 6: Perform Gene Set Enrichment Analysis"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2019-08-21 12:11:21,016 Warning: No enrich terms using library KEGG_2019_Human when cutoff = 0.05\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "           Gene_set                                             Term Overlap  \\\n",
      "0   KEGG_2019_Human                                      Endocytosis   2/244   \n",
      "1   KEGG_2019_Human                    Glycosaminoglycan degradation    1/19   \n",
      "2   KEGG_2019_Human         Pentose and glucuronate interconversions    1/34   \n",
      "3   KEGG_2019_Human                                      Ferroptosis    1/40   \n",
      "4   KEGG_2019_Human             Porphyrin and chlorophyll metabolism    1/42   \n",
      "5   KEGG_2019_Human                               Mineral absorption    1/51   \n",
      "6   KEGG_2019_Human            Regulation of lipolysis in adipocytes    1/55   \n",
      "7   KEGG_2019_Human                  Fc epsilon RI signaling pathway    1/68   \n",
      "8   KEGG_2019_Human                  Adipocytokine signaling pathway    1/69   \n",
      "9   KEGG_2019_Human                           ErbB signaling pathway    1/85   \n",
      "10  KEGG_2019_Human                           GnRH signaling pathway    1/93   \n",
      "11  KEGG_2019_Human                T cell receptor signaling pathway   1/101   \n",
      "12  KEGG_2019_Human             Toll-like receptor signaling pathway   1/104   \n",
      "13  KEGG_2019_Human                                  Drug metabolism   1/108   \n",
      "14  KEGG_2019_Human                            TNF signaling pathway   1/110   \n",
      "15  KEGG_2019_Human                   Neurotrophin signaling pathway   1/119   \n",
      "16  KEGG_2019_Human                                         Lysosome   1/123   \n",
      "17  KEGG_2019_Human                       Osteoclast differentiation   1/127   \n",
      "18  KEGG_2019_Human                        Relaxin signaling pathway   1/130   \n",
      "19  KEGG_2019_Human           Fluid shear stress and atherosclerosis   1/139   \n",
      "20  KEGG_2019_Human                                      Necroptosis   1/162   \n",
      "21  KEGG_2019_Human                                      Hepatitis B   1/163   \n",
      "22  KEGG_2019_Human      Protein processing in endoplasmic reticulum   1/165   \n",
      "23  KEGG_2019_Human                                   Tight junction   1/170   \n",
      "24  KEGG_2019_Human                                      Influenza A   1/171   \n",
      "25  KEGG_2019_Human                                       Alcoholism   1/180   \n",
      "26  KEGG_2019_Human  Kaposi sarcoma-associated herpesvirus infection   1/186   \n",
      "27  KEGG_2019_Human                     Epstein-Barr virus infection   1/201   \n",
      "28  KEGG_2019_Human         Human immunodeficiency virus 1 infection   1/212   \n",
      "29  KEGG_2019_Human                           cAMP signaling pathway   1/212   \n",
      "30  KEGG_2019_Human                           MAPK signaling pathway   1/295   \n",
      "31  KEGG_2019_Human          Neuroactive ligand-receptor interaction   1/338   \n",
      "32  KEGG_2019_Human                 Herpes simplex virus 1 infection   1/492   \n",
      "\n",
      "     P-value  Adjusted P-value  Old P-value  Old Adjusted P-value  Odds Ratio  \\\n",
      "0   0.012246               1.0            0                     0   11.709602   \n",
      "1   0.013222               1.0            0                     0   75.187970   \n",
      "2   0.023546               1.0            0                     0   42.016807   \n",
      "3   0.027648               1.0            0                     0   35.714286   \n",
      "4   0.029011               1.0            0                     0   34.013605   \n",
      "5   0.035125               1.0            0                     0   28.011204   \n",
      "6   0.037831               1.0            0                     0   25.974026   \n",
      "7   0.046577               1.0            0                     0   21.008403   \n",
      "8   0.047246               1.0            0                     0   20.703934   \n",
      "9   0.057902               1.0            0                     0   16.806723   \n",
      "10  0.063188               1.0            0                     0   15.360983   \n",
      "11  0.068447               1.0            0                     0   14.144272   \n",
      "12  0.070412               1.0            0                     0   13.736264   \n",
      "13  0.073026               1.0            0                     0   13.227513   \n",
      "14  0.074330               1.0            0                     0   12.987013   \n",
      "15  0.080179               1.0            0                     0   12.004802   \n",
      "16  0.082767               1.0            0                     0   11.614402   \n",
      "17  0.085349               1.0            0                     0   11.248594   \n",
      "18  0.087280               1.0            0                     0   10.989011   \n",
      "19  0.093053               1.0            0                     0   10.277492   \n",
      "20  0.107652               1.0            0                     0    8.818342   \n",
      "21  0.108281               1.0            0                     0    8.764242   \n",
      "22  0.109540               1.0            0                     0    8.658009   \n",
      "23  0.112678               1.0            0                     0    8.403361   \n",
      "24  0.113304               1.0            0                     0    8.354219   \n",
      "25  0.118924               1.0            0                     0    7.936508   \n",
      "26  0.122652               1.0            0                     0    7.680492   \n",
      "27  0.131908               1.0            0                     0    7.107321   \n",
      "28  0.138638               1.0            0                     0    6.738544   \n",
      "29  0.138638               1.0            0                     0    6.738544   \n",
      "30  0.187879               1.0            0                     0    4.842615   \n",
      "31  0.212349               1.0            0                     0    4.226543   \n",
      "32  0.294481               1.0            0                     0    2.903600   \n",
      "\n",
      "    Combined Score      Genes  \n",
      "0        51.551753  EHD4;RBSN  \n",
      "1       325.251722       GUSB  \n",
      "2       157.512231       GUSB  \n",
      "3       128.150601       FTH1  \n",
      "4       120.410705       GUSB  \n",
      "5        93.804869       FTH1  \n",
      "6        85.055098        NPY  \n",
      "7        64.425482     MAP2K7  \n",
      "8        63.196222        NPY  \n",
      "9        47.882415     MAP2K7  \n",
      "10       42.421483     MAP2K7  \n",
      "11       37.930681     MAP2K7  \n",
      "12       36.447753     MAP2K7  \n",
      "13       34.615688       GUSB  \n",
      "14       33.756385     MAP2K7  \n",
      "15       30.294105     MAP2K7  \n",
      "16       28.939913       GUSB  \n",
      "17       27.682922     MAP2K7  \n",
      "18       26.798134     MAP2K7  \n",
      "19       24.404796     MAP2K7  \n",
      "20       19.654813       FTH1  \n",
      "21       19.483111     MAP2K7  \n",
      "22       19.146925     MAP2K7  \n",
      "23       18.346400     MAP2K7  \n",
      "24       18.192793     MAP2K7  \n",
      "25       16.898974        NPY  \n",
      "26       16.116776     MAP2K7  \n",
      "27       14.396947     MAP2K7  \n",
      "28       13.314614     MAP2K7  \n",
      "29       13.314614        NPY  \n",
      "30        8.096649     MAP2K7  \n",
      "31        6.549136        NPY  \n",
      "32        3.549774     ZNF605  \n",
      "            Gene_set                                         Term Overlap  \\\n",
      "0    KEGG_2019_Human            Ribosome biogenesis in eukaryotes  20/101   \n",
      "1    KEGG_2019_Human                                  Spliceosome  21/134   \n",
      "2    KEGG_2019_Human                    mRNA surveillance pathway   13/91   \n",
      "3    KEGG_2019_Human                                RNA transport  17/165   \n",
      "4    KEGG_2019_Human                     Hepatocellular carcinoma  14/168   \n",
      "5    KEGG_2019_Human                               RNA polymerase    5/31   \n",
      "6    KEGG_2019_Human               Ubiquitin mediated proteolysis   9/137   \n",
      "7    KEGG_2019_Human            Thyroid hormone signaling pathway   7/116   \n",
      "8    KEGG_2019_Human                              Mismatch repair    3/23   \n",
      "9    KEGG_2019_Human                            Pancreatic cancer    5/75   \n",
      "10   KEGG_2019_Human                               Thyroid cancer    3/37   \n",
      "11   KEGG_2019_Human                Cytosolic DNA-sensing pathway    4/63   \n",
      "12   KEGG_2019_Human                        Wnt signaling pathway   7/158   \n",
      "13   KEGG_2019_Human                 NF-kappa B signaling pathway    5/95   \n",
      "14   KEGG_2019_Human                               Bladder cancer    3/41   \n",
      "15   KEGG_2019_Human  Protein processing in endoplasmic reticulum   7/165   \n",
      "16   KEGG_2019_Human                            Adherens junction    4/72   \n",
      "17   KEGG_2019_Human                                  Influenza A   7/171   \n",
      "18   KEGG_2019_Human                                      Measles   6/138   \n",
      "19   KEGG_2019_Human         Other types of O-glycan biosynthesis    2/22   \n",
      "20   KEGG_2019_Human                                      Malaria    3/49   \n",
      "21   KEGG_2019_Human      Biosynthesis of unsaturated fatty acids    2/27   \n",
      "22   KEGG_2019_Human                           Lysine degradation    3/59   \n",
      "23   KEGG_2019_Human                                    Mitophagy    3/65   \n",
      "24   KEGG_2019_Human                   Non-small cell lung cancer    3/66   \n",
      "25   KEGG_2019_Human                 Longevity regulating pathway   4/102   \n",
      "26   KEGG_2019_Human  Alanine, aspartate and glutamate metabolism    2/35   \n",
      "27   KEGG_2019_Human                        p53 signaling pathway    3/72   \n",
      "28   KEGG_2019_Human     Glycine, serine and threonine metabolism    2/40   \n",
      "29   KEGG_2019_Human                                Thermogenesis   7/231   \n",
      "..               ...                                          ...     ...   \n",
      "129  KEGG_2019_Human                   Hematopoietic cell lineage    1/97   \n",
      "130  KEGG_2019_Human                         Pancreatic secretion    1/98   \n",
      "131  KEGG_2019_Human                 Choline metabolism in cancer    1/99   \n",
      "132  KEGG_2019_Human                      HIF-1 signaling pathway   1/100   \n",
      "133  KEGG_2019_Human            T cell receptor signaling pathway   1/101   \n",
      "134  KEGG_2019_Human                                Melanogenesis   1/101   \n",
      "135  KEGG_2019_Human                                Axon guidance   2/181   \n",
      "136  KEGG_2019_Human                    Th17 cell differentiation   1/107   \n",
      "137  KEGG_2019_Human                        TNF signaling pathway   1/110   \n",
      "138  KEGG_2019_Human                    Calcium signaling pathway   2/188   \n",
      "139  KEGG_2019_Human         Leukocyte transendothelial migration   1/112   \n",
      "140  KEGG_2019_Human                           Huntington disease   2/193   \n",
      "141  KEGG_2019_Human               Sphingolipid signaling pathway   1/119   \n",
      "142  KEGG_2019_Human                          Platelet activation   1/124   \n",
      "143  KEGG_2019_Human                            Purine metabolism   1/129   \n",
      "144  KEGG_2019_Human     Human immunodeficiency virus 1 infection   2/212   \n",
      "145  KEGG_2019_Human    Natural killer cell mediated cytotoxicity   1/131   \n",
      "146  KEGG_2019_Human                   PI3K-Akt signaling pathway   4/354   \n",
      "147  KEGG_2019_Human                       FoxO signaling pathway   1/132   \n",
      "148  KEGG_2019_Human             Herpes simplex virus 1 infection   6/492   \n",
      "149  KEGG_2019_Human                    Insulin signaling pathway   1/137   \n",
      "150  KEGG_2019_Human       Cytokine-cytokine receptor interaction   3/294   \n",
      "151  KEGG_2019_Human              Human cytomegalovirus infection   2/225   \n",
      "152  KEGG_2019_Human                        Ras signaling pathway   2/232   \n",
      "153  KEGG_2019_Human                       mTOR signaling pathway   1/152   \n",
      "154  KEGG_2019_Human                   Oxytocin signaling pathway   1/153   \n",
      "155  KEGG_2019_Human                   cGMP-PKG signaling pathway   1/166   \n",
      "156  KEGG_2019_Human                                 Tuberculosis   1/179   \n",
      "157  KEGG_2019_Human                       Rap1 signaling pathway   1/206   \n",
      "158  KEGG_2019_Human                                  Endocytosis   1/244   \n",
      "\n",
      "          P-value  Adjusted P-value  Old P-value  Old Adjusted P-value  \\\n",
      "0    1.734349e-14      5.341794e-12            0                     0   \n",
      "1    4.867850e-13      7.496489e-11            0                     0   \n",
      "2    4.457407e-08      4.576271e-06            0                     0   \n",
      "3    5.744773e-08      4.423475e-06            0                     0   \n",
      "4    1.049896e-05      6.467360e-04            0                     0   \n",
      "5    3.954894e-04      2.030179e-02            0                     0   \n",
      "6    2.160703e-03      9.507094e-02            0                     0   \n",
      "7    1.023745e-02      3.941419e-01            0                     0   \n",
      "8    1.131754e-02      3.873115e-01            0                     0   \n",
      "9    1.926734e-02      5.934341e-01            0                     0   \n",
      "10   4.023428e-02      1.000000e+00            0                     0   \n",
      "11   4.084921e-02      1.000000e+00            0                     0   \n",
      "12   4.553337e-02      1.000000e+00            0                     0   \n",
      "13   4.660759e-02      1.000000e+00            0                     0   \n",
      "14   5.201160e-02      1.000000e+00            0                     0   \n",
      "15   5.508553e-02      1.000000e+00            0                     0   \n",
      "16   6.126004e-02      1.000000e+00            0                     0   \n",
      "17   6.419780e-02      1.000000e+00            0                     0   \n",
      "18   6.621038e-02      1.000000e+00            0                     0   \n",
      "19   7.460095e-02      1.000000e+00            0                     0   \n",
      "20   7.987912e-02      1.000000e+00            0                     0   \n",
      "21   1.060989e-01      1.000000e+00            0                     0   \n",
      "22   1.218001e-01      1.000000e+00            0                     0   \n",
      "23   1.500627e-01      1.000000e+00            0                     0   \n",
      "24   1.549635e-01      1.000000e+00            0                     0   \n",
      "25   1.593514e-01      1.000000e+00            0                     0   \n",
      "26   1.620024e-01      1.000000e+00            0                     0   \n",
      "27   1.853426e-01      1.000000e+00            0                     0   \n",
      "28   1.991056e-01      1.000000e+00            0                     0   \n",
      "29   2.006142e-01      1.000000e+00            0                     0   \n",
      "..            ...               ...          ...                   ...   \n",
      "129  8.678703e-01      1.000000e+00            0                     0   \n",
      "130  8.706054e-01      1.000000e+00            0                     0   \n",
      "131  8.732840e-01      1.000000e+00            0                     0   \n",
      "132  8.759073e-01      1.000000e+00            0                     0   \n",
      "133  8.784764e-01      1.000000e+00            0                     0   \n",
      "134  8.784764e-01      1.000000e+00            0                     0   \n",
      "135  8.900098e-01      1.000000e+00            0                     0   \n",
      "136  8.928143e-01      1.000000e+00            0                     0   \n",
      "137  8.993372e-01      1.000000e+00            0                     0   \n",
      "138  9.021109e-01      1.000000e+00            0                     0   \n",
      "139  9.034643e-01      1.000000e+00            0                     0   \n",
      "140  9.099824e-01      1.000000e+00            0                     0   \n",
      "141  9.166242e-01      1.000000e+00            0                     0   \n",
      "142  9.249132e-01      1.000000e+00            0                     0   \n",
      "143  9.323799e-01      1.000000e+00            0                     0   \n",
      "144  9.348027e-01      1.000000e+00            0                     0   \n",
      "145  9.351548e-01      1.000000e+00            0                     0   \n",
      "146  9.358532e-01      1.000000e+00            0                     0   \n",
      "147  9.364994e-01      1.000000e+00            0                     0   \n",
      "148  9.419269e-01      1.000000e+00            0                     0   \n",
      "149  9.428164e-01      1.000000e+00            0                     0   \n",
      "150  9.435540e-01      1.000000e+00            0                     0   \n",
      "151  9.478909e-01      1.000000e+00            0                     0   \n",
      "152  9.538613e-01      1.000000e+00            0                     0   \n",
      "153  9.582472e-01      1.000000e+00            0                     0   \n",
      "154  9.591138e-01      1.000000e+00            0                     0   \n",
      "155  9.688747e-01      1.000000e+00            0                     0   \n",
      "156  9.763095e-01      1.000000e+00            0                     0   \n",
      "157  9.865680e-01      1.000000e+00            0                     0   \n",
      "158  9.939635e-01      1.000000e+00            0                     0   \n",
      "\n",
      "     Odds Ratio  Combined Score  \\\n",
      "0      9.612612      304.580979   \n",
      "1      7.607593      215.682521   \n",
      "2      6.934813      117.379428   \n",
      "3      5.001471       83.386477   \n",
      "4      4.045307       46.376352   \n",
      "5      7.829627       61.348157   \n",
      "6      3.189001       19.571927   \n",
      "7      2.929361       13.421459   \n",
      "8      6.331786       28.375271   \n",
      "9      3.236246       12.781048   \n",
      "10     3.935975       12.646428   \n",
      "11     3.082139        9.856273   \n",
      "12     2.150670        6.644085   \n",
      "13     2.554931        7.833398   \n",
      "14     3.551977       10.500670   \n",
      "15     2.059429        5.970014   \n",
      "16     2.696872        7.531358   \n",
      "17     1.987169        5.456340   \n",
      "18     2.110595        5.730093   \n",
      "19     4.413063       11.454554   \n",
      "20     2.972063        7.511118   \n",
      "21     3.595829        8.066823   \n",
      "22     2.468323        5.196743   \n",
      "23     2.240478        4.249519   \n",
      "24     2.206531        4.114223   \n",
      "25     1.903674        3.496371   \n",
      "26     2.773925        5.048943   \n",
      "27     2.022654        3.409283   \n",
      "28     2.427184        3.917281   \n",
      "29     1.471021        2.363006   \n",
      "..          ...             ...   \n",
      "129    0.500450        0.070920   \n",
      "130    0.495344        0.068638   \n",
      "131    0.490340        0.066438   \n",
      "132    0.485437        0.064318   \n",
      "133    0.480631        0.062273   \n",
      "134    0.480631        0.062273   \n",
      "135    0.536394        0.062502   \n",
      "136    0.453679        0.051437   \n",
      "137    0.441306        0.046821   \n",
      "138    0.516422        0.053201   \n",
      "139    0.433426        0.044001   \n",
      "140    0.503043        0.047452   \n",
      "141    0.407930        0.035513   \n",
      "142    0.391481        0.030557   \n",
      "143    0.376308        0.026347   \n",
      "144    0.457959        0.030876   \n",
      "145    0.370563        0.024844   \n",
      "146    0.548516        0.036365   \n",
      "147    0.367755        0.024127   \n",
      "148    0.591996        0.035418   \n",
      "149    0.354333        0.020864   \n",
      "150    0.495344        0.028780   \n",
      "151    0.431499        0.023092   \n",
      "152    0.418480        0.019768   \n",
      "153    0.319366        0.013621   \n",
      "154    0.317279        0.013245   \n",
      "155    0.292432        0.009247   \n",
      "156    0.271194        0.006502   \n",
      "157    0.235649        0.003187   \n",
      "158    0.198950        0.001205   \n",
      "\n",
      "                                                 Genes  \n",
      "0    NOP58;UTP6;CSNK2A1;UTP4;WDR3;RPP40;HEATR1;WDR7...  \n",
      "1    SF3B4;TCERG1;AQR;RBM25;SF3B2;EIF4A3;DDX23;PRPF...  \n",
      "2    UPF2;UPF1;SMG1;RNGTT;CPSF1;RNMT;CPSF3;EIF4A3;C...  \n",
      "3    UPF2;UPF1;GEMIN2;EIF4A3;RPP40;NUP153;CASC3;SEN...  \n",
      "4    SMARCE1;SMARCD1;SMARCC1;SMARCB1;PHF10;CDKN2A;A...  \n",
      "5                   POLR3A;POLR3B;POLR2B;POLR3C;POLR3E  \n",
      "6    UBE2C;UBE2S;FBXO2;UBR5;KEAP1;UBE2J2;SAE1;PRPF1...  \n",
      "7              MED12;MED1;MED14;MED24;STAT1;TP53;MED17  \n",
      "8                                       MSH6;RFC4;MSH2  \n",
      "9                       STAT1;CDKN2A;ERBB2;TP53;BCL2L1  \n",
      "10                                     PAX8;CCDC6;TP53  \n",
      "11                         POLR3A;POLR3B;POLR3C;POLR3E  \n",
      "12         SFRP2;CSNK2A1;TBL1XR1;CHD8;WNT7A;SENP2;TP53  \n",
      "13                     CD40;VCAM1;CSNK2A1;PARP1;BCL2L1  \n",
      "14                                   CDKN2A;ERBB2;TP53  \n",
      "15      GANAB;NPLOC4;FBXO2;EIF2AK2;UBE2J2;PDIA6;HSPBP1  \n",
      "16                         CSNK2A1;ERBB2;WASF1;NECTIN3  \n",
      "17          NXF1;XPO1;STAT1;STAT2;TNFSF10;EIF2AK2;RAE1  \n",
      "18             CSNK2A1;STAT1;STAT2;EIF2AK2;TP53;BCL2L1  \n",
      "19                                     POFUT1;COLGALT1  \n",
      "20                                    CD40;VCAM1;THBS2  \n",
      "21                                         ACOT7;FADS1  \n",
      "22                                EHMT2;KMT2B;COLGALT1  \n",
      "23                                 CSNK2A1;TP53;BCL2L1  \n",
      "24                                   CDKN2A;ERBB2;TP53  \n",
      "25                             EHMT2;RB1CC1;ATG13;TP53  \n",
      "26                                           CAD;NAT8L  \n",
      "27                                  CDKN2A;TP53;BCL2L1  \n",
      "28                                            GLDC;CBS  \n",
      "29   SMARCE1;SMARCD1;SMARCC1;SMARCB1;ACTL6A;ARID1A;...  \n",
      "..                                                 ...  \n",
      "129                                               CD38  \n",
      "130                                               CD38  \n",
      "131                                              WASF1  \n",
      "132                                              ERBB2  \n",
      "133                                               PAK2  \n",
      "134                                              WNT7A  \n",
      "135                                         L1CAM;PAK2  \n",
      "136                                              STAT1  \n",
      "137                                              VCAM1  \n",
      "138                                         ERBB2;CD38  \n",
      "139                                              VCAM1  \n",
      "140                                        POLR2B;TP53  \n",
      "141                                               TP53  \n",
      "142                                              PRKCI  \n",
      "143                                               GMPS  \n",
      "144                                        PAK2;BCL2L1  \n",
      "145                                            TNFSF10  \n",
      "146                            ERBB2;THBS2;TP53;BCL2L1  \n",
      "147                                            TNFSF10  \n",
      "148               NXF1;STAT1;STAT2;EIF2AK2;TP53;BCL2L1  \n",
      "149                                              PRKCI  \n",
      "150                                 CD40;TNFSF10;INHBA  \n",
      "151                                        CDKN2A;TP53  \n",
      "152                                        PAK2;BCL2L1  \n",
      "153                                              WNT7A  \n",
      "154                                               CD38  \n",
      "155                                           GTF2IRD1  \n",
      "156                                              STAT1  \n",
      "157                                              PRKCI  \n",
      "158                                              PRKCI  \n",
      "\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[159 rows x 10 columns]\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2019-08-21 12:11:31,119 Warning: No enrich terms using library KEGG_2019_Human when cutoff = 0.05\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "          Gene_set                                      Term Overlap  \\\n",
      "0  KEGG_2019_Human   Glyoxylate and dicarboxylate metabolism    1/30   \n",
      "1  KEGG_2019_Human  Glycine, serine and threonine metabolism    1/40   \n",
      "2  KEGG_2019_Human                             RNA transport   1/165   \n",
      "\n",
      "    P-value  Adjusted P-value  Old P-value  Old Adjusted P-value  Odds Ratio  \\\n",
      "0  0.011939               1.0            0                     0   83.333333   \n",
      "1  0.015891               1.0            0                     0   62.500000   \n",
      "2  0.064136               1.0            0                     0   15.151515   \n",
      "\n",
      "   Combined Score Genes  \n",
      "0      368.994341  GLDC  \n",
      "1      258.874854  GLDC  \n",
      "2       41.617414  XPO5  \n"
     ]
    }
   ],
   "source": [
    "for col in sig_cols:\n",
    "    col_name = col.columns[0]\n",
    "    gene_name_list = list(col.index)\n",
    "    enrichment = gp.enrichr(gene_list = gene_name_list, \n",
    "                            description=col_name, \n",
    "                            gene_sets='KEGG_2019_Human',\n",
    "                            outdir='test/endometrial')\n",
    "    print(enrichment.res2d)\n",
    "    barplot(enrichment.res2d, title=col_name)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Step 7: Connect findings with the Genome Druggable Interactive Database (DGIdb)\n",
    "\n",
    "Our goal is to find personalized medicines based on specific clinical attributes, for individual patients, and to see how their current medicines are helping, hurting, or are indifferent towards their cancer treatment."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Step 7a: Personalized Medicine by Clinical Attributes\n",
    "After performing our outlier analyses, we find that there are groups of patients that have a common set of significantly up or down regulated genes grouped by clinical attributes. Here we will use those groups to find drugs best suited to both bring those gene enrichments to normal levels, and aid in the treatment of their cancer\n",
    "\n",
    "First, we will perform HTTP GET requests to DGIdb for all of our significantly up-regulated genes by clinical attribute.  Note, that we will want to look for drugs with an interaction type of 'inhibitor' for up-regulated genes."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "#Here we will link clinical attributes with significantly up-regulated genes\n",
    "sig_genes_up = {}\n",
    "for i, col in enumerate(sig_cols):\n",
    "    list_of_genes = list(col.index)\n",
    "    sig_genes_up[sig_cols[i].columns[0][:-9]] = list_of_genes"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "This will perform a general HTTP GET request to DGIdb.  While this is fast, it would be worthwile to search specifically for drugs that are inhibitors to patients' significantly up-regulated genes, so we will compare both queries below."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {},
   "outputs": [],
   "source": [
    "#General GET Request\n",
    "requests_up = list(map(bf.dgidb_get_request, sig_genes_up.values()))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "UP-REGULATED GENERAL REQUEST:\n",
      "\n",
      "{\n",
      "    \"Proteomics_Tumor_Normal_Other_tumor\": {\n",
      "        \"FTH1\": {\n",
      "            \"IRON DEXTRAN\": [\n",
      "                \"other\"\n",
      "            ]\n",
      "        },\n",
      "        \"GNLY\": {\n",
      "            \"MYELOPEROXIDASE\": []\n",
      "        },\n",
      "        \"MAP2K7\": {\n",
      "            \"COBIMETINIB\": [\n",
      "                \"allosteric modulator\",\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"Refametinib\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TRAMETINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AZD-8330\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"SELUMETINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PD-0325901\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DABRAFENIB MESYLATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"BINIMETINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"IODOACETAMIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"WX-554\": []\n",
      "        },\n",
      "        \"NPY\": {\n",
      "            \"HALOPERIDOL\": [],\n",
      "            \"ESTRADIOL BENZOATE\": [],\n",
      "            \"BROMOCRIPTINE\": [],\n",
      "            \"ETHER\": [],\n",
      "            \"ROSIGLITAZONE\": [],\n",
      "            \"K-252A\": [],\n",
      "            \"CHEMBL1230906\": []\n",
      "        }\n",
      "    },\n",
      "    \"Histologic_type_Serous\": {\n",
      "        \"ACTL6A\": {\n",
      "            \"CHEMBL225155\": [\n",
      "                \"agonist\"\n",
      "            ]\n",
      "        },\n",
      "        \"ARID1A\": {\n",
      "            \"TRASTUZUMAB\": [],\n",
      "            \"DASATINIB\": [],\n",
      "            \"CHEMBL3287735\": []\n",
      "        },\n",
      "        \"BCL2L1\": {\n",
      "            \"CHEMBL106708\": [],\n",
      "            \"NAVITOCLAX\": [\n",
      "                \"antagonist\",\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ISOSORBIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL376408\": [\n",
      "                \"antagonist\"\n",
      "            ],\n",
      "            \"VENETOCLAX\": [\n",
      "                \"antagonist\"\n",
      "            ],\n",
      "            \"OBATOCLAX MESYLATE\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"CAD\": {\n",
      "            \"ASPARTIC ACID\": [],\n",
      "            \"PALA\": []\n",
      "        },\n",
      "        \"CARM1\": {\n",
      "            \"CHEMBL468927\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PREGNENOLONE\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"CBS\": {\n",
      "            \"PYRIDOXAL PHOSPHATE\": [\n",
      "                \"cofactor\"\n",
      "            ],\n",
      "            \"S-ADENOSYL-L-METHIONINE\": [\n",
      "                \"activator\"\n",
      "            ],\n",
      "            \"SERINE\": [],\n",
      "            \"CYSTEINE\": [],\n",
      "            \"ARSENIC\": []\n",
      "        },\n",
      "        \"CD38\": {\n",
      "            \"DARATUMUMAB\": [\n",
      "                \"inhibitor\",\n",
      "                \"antibody\"\n",
      "            ],\n",
      "            \"ISATUXIMAB\": [\n",
      "                \"antibody\"\n",
      "            ],\n",
      "            \"THROMBIN\": [],\n",
      "            \"HuMax-CD38\": [],\n",
      "            \"SAR-650984\": []\n",
      "        },\n",
      "        \"CD40\": {\n",
      "            \"FLUDARABINE\": [],\n",
      "            \"HYDROQUINONE\": [],\n",
      "            \"STREPTOZOTOCIN\": [],\n",
      "            \"TETANUS TOXOID\": [],\n",
      "            \"DACETUZUMAB\": [\n",
      "                \"antibody\",\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PG-102\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LUCATUMUMAB\": [],\n",
      "            \"TENELIXIMAB\": [\n",
      "                \"partial agonist\"\n",
      "            ]\n",
      "        },\n",
      "        \"CDK11B\": {\n",
      "            \"AZD-5438\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PHA-793887\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"Roniciclib\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AT-7519\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"CDK12\": {\n",
      "            \"OLAPARIB\": [],\n",
      "            \"AZD-5438\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PHA-793887\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AT-7519\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"Roniciclib\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"CDKN2A\": {\n",
      "            \"PALBOCICLIB\": [],\n",
      "            \"LETROZOLE\": [],\n",
      "            \"Ribociclib\": [],\n",
      "            \"Roniciclib\": [],\n",
      "            \"ABEMACICLIB\": [],\n",
      "            \"ILORASERTIB\": [],\n",
      "            \"PANITUMUMAB\": [],\n",
      "            \"TRAMETINIB\": [],\n",
      "            \"GEMCITABINE\": [],\n",
      "            \"CHEMBL1231206\": [],\n",
      "            \"PF-00477736\": [],\n",
      "            \"GSK-461364\": [],\n",
      "            \"HMN-214\": [],\n",
      "            \"ALVOCIDIB\": [],\n",
      "            \"IMATINIB\": [],\n",
      "            \"CARBOPLATIN\": [],\n",
      "            \"PACLITAXEL\": [],\n",
      "            \"INK-128\": [],\n",
      "            \"ALECTINIB\": [],\n",
      "            \"CRIZOTINIB\": []\n",
      "        },\n",
      "        \"CIP2A\": {\n",
      "            \"GEMCITABINE\": []\n",
      "        },\n",
      "        \"CSNK2A1\": {\n",
      "            \"SILMITASERTIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL92361\": [],\n",
      "            \"CHEMBL270512\": [],\n",
      "            \"RESVERATROL\": [],\n",
      "            \"CHEMBL574060\": [],\n",
      "            \"BENZAMIDINE\": [],\n",
      "            \"CHEMBL572879\": [],\n",
      "            \"CHEMBL1230989\": [],\n",
      "            \"TETRABROMOBENZOTRIAZOLE\": [],\n",
      "            \"CHEMBL376505\": [],\n",
      "            \"CHEMBL222476\": [],\n",
      "            \"EMODIN\": [],\n",
      "            \"CHEMBL273101\": [],\n",
      "            \"CHEMBL404508\": [],\n",
      "            \"CHEMBL231095\": [],\n",
      "            \"CHEMBL389767\": [],\n",
      "            \"CHEMBL438303\": [],\n",
      "            \"CHEMBL230347\": [],\n",
      "            \"CHEMBL230137\": [],\n",
      "            \"CHEMBL230354\": [],\n",
      "            \"DICHLORORIBOBENZIMIDAZOLE\": [],\n",
      "            \"QUINALIZARIN\": [],\n",
      "            \"ELLAGIC ACID\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"HEPARIN\": []\n",
      "        },\n",
      "        \"DNMT3A\": {\n",
      "            \"AZACITIDINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DECITABINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DAUNORUBICIN\": [],\n",
      "            \"IDARUBICIN\": []\n",
      "        },\n",
      "        \"EHMT2\": {\n",
      "            \"CHEMBL569864\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL1231795\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL2441082\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"EIF2AK2\": {\n",
      "            \"CHEMBL1802728\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL235641\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"INTERFERON ALFA-2B\": []\n",
      "        },\n",
      "        \"ERBB2\": {\n",
      "            \"LAPATINIB\": [\n",
      "                \"antagonist\",\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PERTUZUMAB\": [\n",
      "                \"inhibitor\",\n",
      "                \"antibody\"\n",
      "            ],\n",
      "            \"TRASTUZUMAB\": [\n",
      "                \"inhibitor\",\n",
      "                \"antibody\"\n",
      "            ],\n",
      "            \"MARGETUXIMAB\": [\n",
      "                \"inhibitor\",\n",
      "                \"antibody\"\n",
      "            ],\n",
      "            \"ACALABRUTINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AEE-788\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AFATINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AC-480\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"BMS-690514\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CANERTINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CP-724714\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CUDC-101\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DACOMITINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"FALNIDAMOL\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"IBRUTINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MUBRITINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"NERATINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"Poziotinib\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"SAPITINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TESEVATINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"IGN-311\": [],\n",
      "            \"TRASTUZUMAB EMTANSINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"EVEROLIMUS\": [],\n",
      "            \"FULVESTRANT\": [],\n",
      "            \"PALBOCICLIB\": [],\n",
      "            \"TYRPHOSTIN AG 879\": [],\n",
      "            \"ANTHRAQUINONE\": [],\n",
      "            \"CHLORAMBUCIL\": [],\n",
      "            \"DEPSIPEPTIDE\": [],\n",
      "            \"DIETHYLSTILBESTROL\": [],\n",
      "            \"EMODIN\": [],\n",
      "            \"ETHYL NITROSOUREA\": [],\n",
      "            \"EPIRUBICIN\": [],\n",
      "            \"FILGRASTIM\": [],\n",
      "            \"FLOXURIDINE\": [],\n",
      "            \"ROMIDEPSIN\": [],\n",
      "            \"GEFITINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"GEMCITABINE\": [],\n",
      "            \"EPIGALOCATECHIN GALLATE\": [],\n",
      "            \"HYDROCORTISONE\": [],\n",
      "            \"PROXYPHYLLINE\": [],\n",
      "            \"ISOFLAVONE\": [],\n",
      "            \"MECHLORETHAMINE HYDROCHLORIDE\": [],\n",
      "            \"CHEMBL35482\": [],\n",
      "            \"VORINOSTAT\": [],\n",
      "            \"TAMOXIFEN\": [],\n",
      "            \"URACIL\": [],\n",
      "            \"VITAMIN E\": [],\n",
      "            \"CHEMBL2141478\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"SB-243213\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"INSM-18\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CIMAGLERMIN ALFA\": [],\n",
      "            \"Irbinitinib\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PELITINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"T-DM1\": [\n",
      "                \"antibody\"\n",
      "            ],\n",
      "            \"S-222611\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TAK-285\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LAPATINIB DITOSYLATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MOMELOTINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LITHOCHOLIC ACID\": [\n",
      "                \"antibody\"\n",
      "            ],\n",
      "            \"GANCICLOVIR\": [],\n",
      "            \"TIPIFARNIB\": [],\n",
      "            \"OSIMERTINIB\": [],\n",
      "            \"ROCILETINIB\": [],\n",
      "            \"MK-2206\": [],\n",
      "            \"ABEMACICLIB\": [],\n",
      "            \"LETROZOLE\": [],\n",
      "            \"ANASTROZOLE\": [],\n",
      "            \"EXEMESTANE\": [],\n",
      "            \"GONADORELIN\": [],\n",
      "            \"CRIZOTINIB\": [],\n",
      "            \"IRINOTECAN\": [],\n",
      "            \"DOCETAXEL\": [],\n",
      "            \"CAPECITABINE\": [],\n",
      "            \"PICTILISIB\": [],\n",
      "            \"CETUXIMAB\": [],\n",
      "            \"SIROLIMUS\": [],\n",
      "            \"PHENYLTHIOUREA\": [],\n",
      "            \"MM-302\": [],\n",
      "            \"PACLITAXEL\": [],\n",
      "            \"VARLITINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"VS-5584\": [],\n",
      "            \"PKI-179\": [],\n",
      "            \"ARQ-092\": [],\n",
      "            \"BUPARLISIB\": [],\n",
      "            \"BEVACIZUMAB\": [],\n",
      "            \"PONATINIB\": [],\n",
      "            \"SORAFENIB\": [],\n",
      "            \"Pyrotinib\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PA-799\": [],\n",
      "            \"TASELISIB\": [],\n",
      "            \"CUDC-907\": [],\n",
      "            \"IPATASERTIB\": [],\n",
      "            \"COPANLISIB\": [],\n",
      "            \"GEDATOLISIB\": [],\n",
      "            \"AZD-4547\": [],\n",
      "            \"FLUOROURACIL\": [],\n",
      "            \"LEUCOVORIN\": [],\n",
      "            \"OXALIPLATIN\": [],\n",
      "            \"AMG-337\": [],\n",
      "            \"BGB-283\": [],\n",
      "            \"TEMSIROLIMUS\": [],\n",
      "            \"DEPATUXIZUMAB MAFODOTIN\": [],\n",
      "            \"ERLOTINIB\": [],\n",
      "            \"PANITUMUMAB\": [],\n",
      "            \"SELUMETINIB\": [],\n",
      "            \"PILARALISIB (CHEMBL3218575)\": [],\n",
      "            \"CHEMBL1229592\": [],\n",
      "            \"CI-1040\": [],\n",
      "            \"CHEMBL392068\": [],\n",
      "            \"AT-13148\": [],\n",
      "            \"ENTINOSTAT\": [],\n",
      "            \"TRODUSQUEMINE\": [],\n",
      "            \"DOXORUBICIN\": [],\n",
      "            \"CYCLOPHOSPHAMIDE\": [],\n",
      "            \"SUNITINIB\": [],\n",
      "            \"METFORMIN\": [],\n",
      "            \"VINORELBINE BASE\": [],\n",
      "            \"TEGAFUR\": [],\n",
      "            \"LAPULEUCEL-T\": [],\n",
      "            \"RILOTUMUMAB\": [],\n",
      "            \"ONARTUZUMAB\": [],\n",
      "            \"OLAPARIB\": [],\n",
      "            \"SERIBANTUMAB\": [],\n",
      "            \"RAMUCIRUMAB\": [],\n",
      "            \"AZD-8055\": [],\n",
      "            \"BENZONATATE\": [],\n",
      "            \"TIVOZANIB\": [],\n",
      "            \"AFATINIB DIMALEATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"OSIMERTINIB MESYLATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"Allitinib\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"JNJ-26483327\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MP-412\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"Hemay-022\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CANERTINIB DIHYDROCHLORIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DACOMITINIB HYDRATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ERTUMAXOMAB\": [],\n",
      "            \"MDX-210\": [],\n",
      "            \"VANDETANIB\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"FADS1\": {\n",
      "            \"LINOLENIC ACID\": [\n",
      "                \"ligand\"\n",
      "            ],\n",
      "            \"ICOSAPENT\": [\n",
      "                \"agonist\"\n",
      "            ]\n",
      "        },\n",
      "        \"GANAB\": {\n",
      "            \"MIGLITOL\": [\n",
      "                \"antagonist\"\n",
      "            ]\n",
      "        },\n",
      "        \"GLDC\": {\n",
      "            \"PYRIDOXAL PHOSPHATE\": [\n",
      "                \"cofactor\"\n",
      "            ],\n",
      "            \"GLYCINE\": []\n",
      "        },\n",
      "        \"GMPS\": {\n",
      "            \"L-GLUTAMATE\": []\n",
      "        },\n",
      "        \"HCK\": {\n",
      "            \"BOSUTINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"IBRUTINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL1081312\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL306380\": [],\n",
      "            \"CHEMBL286939\": [],\n",
      "            \"QUERCETIN\": [],\n",
      "            \"DASATINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ENMD-981693\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ILORASERTIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"XL-228\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TG100-801\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MASITINIB\": [],\n",
      "            \"NINTEDANIB\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"ILF3\": {\n",
      "            \"CYCLOSPORINE\": []\n",
      "        },\n",
      "        \"INHBA\": {\n",
      "            \"SOTATERCEPT\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"KDM2A\": {\n",
      "            \"CHEMBL2164243\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"KEAP1\": {\n",
      "            \"DIMETHYL FUMARATE\": [\n",
      "                \"inhibitor\",\n",
      "                \"binder\"\n",
      "            ],\n",
      "            \"BARDOXOLONE METHYL\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"KIF11\": {\n",
      "            \"CK0106023\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MONASTROL\": [],\n",
      "            \"CHEMBL205786\": [],\n",
      "            \"CHEMBL228369\": [],\n",
      "            \"CHEMBL481931\": [],\n",
      "            \"(R)-MON-97\": [],\n",
      "            \"CHEMBL205437\": [],\n",
      "            \"CHEMBL204459\": [],\n",
      "            \"CHEMBL380955\": [],\n",
      "            \"FILANESIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ISPINESIB (CHEMBL228814)\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LITRONESIB\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"KIF1A\": {\n",
      "            \"PHOSPHOMETHYLPHOSPHONIC ACID ADENYLATE ESTER\": [],\n",
      "            \"CHEMBL1230989\": []\n",
      "        },\n",
      "        \"KIF2C\": {\n",
      "            \"CHEMBL1230989\": []\n",
      "        },\n",
      "        \"KLC3\": {\n",
      "            \"PHENYLTHIOUREA\": [],\n",
      "            \"FLUOROURACIL\": [],\n",
      "            \"IFOSFAMIDE\": [],\n",
      "            \"OXALIPLATIN\": []\n",
      "        },\n",
      "        \"MED1\": {\n",
      "            \"BECOCALCIDIOL\": []\n",
      "        },\n",
      "        \"MSH2\": {\n",
      "            \"PEMBROLIZUMAB\": [],\n",
      "            \"NIVOLUMAB\": [],\n",
      "            \"IPILIMUMAB\": [],\n",
      "            \"ATEZOLIZUMAB\": [],\n",
      "            \"DURVALUMAB\": []\n",
      "        },\n",
      "        \"MSH6\": {\n",
      "            \"TEMOZOLOMIDE\": [],\n",
      "            \"PEMBROLIZUMAB\": [],\n",
      "            \"NIVOLUMAB\": [],\n",
      "            \"IPILIMUMAB\": [],\n",
      "            \"ATEZOLIZUMAB\": [],\n",
      "            \"DURVALUMAB\": []\n",
      "        },\n",
      "        \"MTHFD2\": {\n",
      "            \"TETRAHYDROFOLATE\": [\n",
      "                \"cofactor\"\n",
      "            ],\n",
      "            \"CHEMBL1161866\": []\n",
      "        },\n",
      "        \"MYO9B\": {\n",
      "            \"MANNOMUSTINE\": [],\n",
      "            \"CAFFEINE\": [],\n",
      "            \"CAPTOPRIL\": [],\n",
      "            \"DIBUCAINE\": [],\n",
      "            \"FELODIPINE\": [],\n",
      "            \"PROPYLTHIOURACIL\": [],\n",
      "            \"VOLANESORSEN SODIUM\": [],\n",
      "            \"STREPTOZOTOCIN\": [],\n",
      "            \"TESTOSTERONE\": [],\n",
      "            \"WORTMANNIN\": [],\n",
      "            \"NIFEDIPINE\": []\n",
      "        },\n",
      "        \"PAK2\": {\n",
      "            \"SELEGILINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"STAUROSPORINE\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"PARP1\": {\n",
      "            \"CHEMBL123904\": [],\n",
      "            \"NIACINAMIDE\": [\n",
      "                \"binder\"\n",
      "            ],\n",
      "            \"CHEMBL401843\": [],\n",
      "            \"CHEMBL123978\": [],\n",
      "            \"CHEMBL125200\": [],\n",
      "            \"CHEMBL134022\": [],\n",
      "            \"CHEMBL338790\": [],\n",
      "            \"VELIPARIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL452800\": [],\n",
      "            \"CHEMBL361054\": [],\n",
      "            \"OLAPARIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"RUCAPARIB\": [\n",
      "                \"inhibitor\",\n",
      "                \"antagonist\"\n",
      "            ],\n",
      "            \"NIRAPARIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"HEPTANOATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TALAZOPARIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"INOSINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"INIPARIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TALAZOPARIB TOSYLATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"RUCAPARIB CAMSYLATE\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"PDF\": {\n",
      "            \"CHEMBL431210\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"PRKCI\": {\n",
      "            \"CEP-2563\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"GF-109203\": [],\n",
      "            \"STAUROSPORINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"GSK-690693\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"(7S)-HYDROXYL-STAUROSPORINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"QUERCETIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MIDOSTAURIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"INGENOL MEBUTATE\": [],\n",
      "            \"SOTRASTAURIN\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"PRRC2A\": {\n",
      "            \"CARBAMAZEPINE\": []\n",
      "        },\n",
      "        \"SMARCA4\": {\n",
      "            \"TRETINOIN\": [],\n",
      "            \"VINORELBINE BASE\": []\n",
      "        },\n",
      "        \"SMARCA5\": {\n",
      "            \"DEXTROSE\": []\n",
      "        },\n",
      "        \"SMARCB1\": {\n",
      "            \"PANOBINOSTAT\": [],\n",
      "            \"PALBOCICLIB\": [],\n",
      "            \"ALVOCIDIB\": [],\n",
      "            \"FENRETINIDE\": [],\n",
      "            \"VORINOSTAT\": [],\n",
      "            \"PENTANAL\": []\n",
      "        },\n",
      "        \"STAT2\": {\n",
      "            \"ISOTRETINOIN\": []\n",
      "        },\n",
      "        \"THBS2\": {\n",
      "            \"CORTICOTROPIN\": [],\n",
      "            \"BEVACIZUMAB\": []\n",
      "        },\n",
      "        \"TK1\": {\n",
      "            \"THYMIDINE_TRIPHOSPHATE\": []\n",
      "        },\n",
      "        \"TNFSF10\": {\n",
      "            \"SODIUM BUTYRATE\": [],\n",
      "            \"TRICHOSTATIN\": []\n",
      "        },\n",
      "        \"TOP1\": {\n",
      "            \"CAMPTOTHECIN\": [],\n",
      "            \"EDOTECARIN\": [],\n",
      "            \"LUCANTHONE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ELSAMITRUCIN\": [],\n",
      "            \"7-ETHYL-10-HYDROXY-CAMPTOTHECIN\": [],\n",
      "            \"SODIUM STIBOGLUCONATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"KARENITECIN\": [],\n",
      "            \"CHEMBL343336\": [],\n",
      "            \"CAFFEINE\": [],\n",
      "            \"CYCLOPHOSPHAMIDE\": [],\n",
      "            \"BECATECARIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ETIRINOTECAN PEGOL\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"IRINOTECAN SUCROSOFATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LURTOTECAN\": [],\n",
      "            \"IRINOTECAN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TOPOTECAN\": [],\n",
      "            \"C-1311 (CHEMBL3545337)\": [],\n",
      "            \"RUBITECAN\": [],\n",
      "            \"IRINOTECAN HYDROCHLORIDE HYDRATE\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"TOP2A\": {\n",
      "            \"TENIPOSIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AMSACRINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"VALRUBICIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"EPIRUBICIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ENOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PEFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TROVAFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LOMEFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"NORFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LEVOFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"OFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PODOFILOX\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MITOXANTRONE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"SPARFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DOXORUBICIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ETOPOSIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"GENISTEIN\": [],\n",
      "            \"FLEROXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LUCANTHONE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"BANOXANTRONE\": [],\n",
      "            \"AMONAFIDE\": [],\n",
      "            \"ELSAMITRUCIN\": [],\n",
      "            \"BERUBICIN HYDROCHLORIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AMRUBICIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"FINAFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DAUNORUBICIN\": [],\n",
      "            \"DEXRAZOXANE\": [],\n",
      "            \"HYDROQUINONE\": [],\n",
      "            \"VINCRISTINE\": [],\n",
      "            \"VOSAROXIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AMRUBICIN HYDROCHLORIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ALDOXORUBICIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"BECATECARIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MM-302\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ETOPOSIDE PHOSPHATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DAUNORUBICIN CITRATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DAUNORUBICIN HYDROCHLORIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DOXORUBICIN HYDROCHLORIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MITOXANTRONE DIHYDROCHLORIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"IDARUBICIN\": [],\n",
      "            \"PACLITAXEL\": [],\n",
      "            \"C-1311 (CHEMBL3545337)\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DACTINOMYCIN\": [],\n",
      "            \"CAMPTOTHECIN\": [],\n",
      "            \"IDARUBICIN HYDROCHLORIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"IDRONOXIL\": []\n",
      "        },\n",
      "        \"TP53\": {\n",
      "            \"TARENFLURBIL\": [],\n",
      "            \"ASPIRIN\": [\n",
      "                \"acetylation\"\n",
      "            ],\n",
      "            \"Lesogaberan\": [],\n",
      "            \"CHEMBL1235116\": [],\n",
      "            \"DIETHYLSTILBESTROL\": [],\n",
      "            \"ENALAPRIL\": [],\n",
      "            \"RIZATRIPTAN\": [],\n",
      "            \"HALOPERIDOL\": [],\n",
      "            \"PROXYPHYLLINE\": [],\n",
      "            \"INOSITOL\": [],\n",
      "            \"INTERFERON ALFA-2B\": [],\n",
      "            \"CHEMBL1221512\": [],\n",
      "            \"METHIMAZOLE\": [],\n",
      "            \"METHYLPREDNISOLONE\": [],\n",
      "            \"MYCOPHENOLIC ACID\": [],\n",
      "            \"PACLITAXEL\": [],\n",
      "            \"PROPYLTHIOURACIL\": [],\n",
      "            \"PUROMYCIN\": [],\n",
      "            \"SIROLIMUS\": [],\n",
      "            \"RITUXIMAB\": [],\n",
      "            \"STREPTONIGRIN\": [],\n",
      "            \"TIRAPAZAMINE\": [],\n",
      "            \"THIOTEPA\": [],\n",
      "            \"TRIFLUOPERAZINE\": [],\n",
      "            \"URSODIOL\": [],\n",
      "            \"BEVACIZUMAB\": [],\n",
      "            \"VESNARINONE\": [],\n",
      "            \"YONDELIS\": [],\n",
      "            \"FLUOROURACIL\": [],\n",
      "            \"GARLIC\": [],\n",
      "            \"GOSSYPOL\": [],\n",
      "            \"GRANISETRON\": [],\n",
      "            \"ZINC CHLORIDE\": [],\n",
      "            \"BORTEZOMIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ABEMACICLIB\": [],\n",
      "            \"AZD-6738\": [],\n",
      "            \"DECITABINE\": [],\n",
      "            \"DOXORUBICIN\": [],\n",
      "            \"GEMCITABINE\": [],\n",
      "            \"MITOMYCIN\": [],\n",
      "            \"AZD-1775\": [],\n",
      "            \"PRAMLINTIDE\": [],\n",
      "            \"DOCETAXEL\": [],\n",
      "            \"SELUMETINIB\": [],\n",
      "            \"TAMOXIFEN\": [],\n",
      "            \"OXALIPLATIN\": [],\n",
      "            \"CETUXIMAB\": [],\n",
      "            \"CAPECITABINE\": [],\n",
      "            \"CARBOPLATIN\": [],\n",
      "            \"GANETESPIB\": [],\n",
      "            \"SELICICLIB\": [],\n",
      "            \"Tepotinib\": [],\n",
      "            \"CRIZOTINIB\": [],\n",
      "            \"CYCLOPHOSPHAMIDE\": [],\n",
      "            \"TOPOTECAN\": [],\n",
      "            \"DASATINIB\": [],\n",
      "            \"DEMCIZUMAB\": [],\n",
      "            \"INK-128\": [],\n",
      "            \"PD-0325901\": [],\n",
      "            \"VX-970\": [],\n",
      "            \"EPIRUBICIN\": [],\n",
      "            \"GEDATOLISIB\": [],\n",
      "            \"ENCORAFENIB\": [],\n",
      "            \"NAVITOCLAX\": [],\n",
      "            \"DABRAFENIB\": [],\n",
      "            \"PF-04217903\": [],\n",
      "            \"DACTOLISIB\": [],\n",
      "            \"IRINOTECAN\": [],\n",
      "            \"CHEMBL376408\": [],\n",
      "            \"ALPELISIB\": [],\n",
      "            \"TRAMETINIB\": [],\n",
      "            \"CYTARABINE\": [],\n",
      "            \"NUTLIN-3\": [],\n",
      "            \"PAZOPANIB\": [],\n",
      "            \"VORINOSTAT\": [],\n",
      "            \"HEMICHOLINIUM-3\": [],\n",
      "            \"PF-00477736\": [],\n",
      "            \"PRODIGIOSIN\": [],\n",
      "            \"TRIFLURIDINE\": [],\n",
      "            \"RG-547\": [],\n",
      "            \"LY-3009120\": [],\n",
      "            \"VEMURAFENIB\": [],\n",
      "            \"DAUNORUBICIN\": [],\n",
      "            \"IFOSFAMIDE\": [],\n",
      "            \"DS-7423\": [],\n",
      "            \"LORLATINIB\": [],\n",
      "            \"SP-600125\": [],\n",
      "            \"PHA-680632\": [],\n",
      "            \"OLAPARIB\": [],\n",
      "            \"AZD-5363\": [],\n",
      "            \"CAPMATINIB\": [],\n",
      "            \"AMG-337\": [],\n",
      "            \"TANESPIMYCIN\": [],\n",
      "            \"PANITUMUMAB\": [],\n",
      "            \"AMG-900\": [],\n",
      "            \"AZD-6482\": [],\n",
      "            \"IBRUTINIB\": [],\n",
      "            \"ALVESPIMYCIN\": [],\n",
      "            \"PIMASERTIB\": [],\n",
      "            \"CHEMBL303958\": [],\n",
      "            \"TEMOZOLOMIDE\": [],\n",
      "            \"RG-7602\": [],\n",
      "            \"ETOPOSIDE\": [],\n",
      "            \"PEMBROLIZUMAB\": [],\n",
      "            \"DUVELISIB\": [],\n",
      "            \"AZD-7762\": [],\n",
      "            \"ERLOTINIB\": [],\n",
      "            \"CHEMBL392068\": []\n",
      "        },\n",
      "        \"TPX2\": {\n",
      "            \"N (g)-NITRO-L-ARGININE\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"TUBB4A\": {\n",
      "            \"EPOTHILONE D\": [],\n",
      "            \"PATUPILONE\": [],\n",
      "            \"LEXIBULIN\": []\n",
      "        },\n",
      "        \"VCAM1\": {\n",
      "            \"CARVEDILOL\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"SUCCINOBUCOL\": [],\n",
      "            \"DEXAMETHASONE\": [],\n",
      "            \"PHORBOL MYRISTATE ACETATE\": [],\n",
      "            \"TROGLITAZONE\": [],\n",
      "            \"MERCAPTOPURINE\": [],\n",
      "            \"CYCLOSPORINE\": []\n",
      "        },\n",
      "        \"WNT7A\": {\n",
      "            \"DIETHYLSTILBESTROL\": []\n",
      "        },\n",
      "        \"XPO1\": {\n",
      "            \"SELINEXOR\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        }\n",
      "    },\n",
      "    \"LVSI_1.0\": {\n",
      "        \"GLDC\": {\n",
      "            \"PYRIDOXAL PHOSPHATE\": [\n",
      "                \"cofactor\"\n",
      "            ],\n",
      "            \"GLYCINE\": []\n",
      "        },\n",
      "        \"HAPLN1\": {\n",
      "            \"HYALURONIC ACID\": [\n",
      "                \"binder\"\n",
      "            ]\n",
      "        },\n",
      "        \"PRRC2A\": {\n",
      "            \"CARBAMAZEPINE\": []\n",
      "        }\n",
      "    }\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "} \n",
      "\n"
     ]
    }
   ],
   "source": [
    "print('UP-REGULATED GENERAL REQUEST:\\n')\n",
    "drug_dict_up = {}\n",
    "for i, request in enumerate(requests_up):\n",
    "    clinical_attribute = sig_cols[i].columns[0][:-9]\n",
    "    drug_dict_up[clinical_attribute] = bf.dgidb_json_parse(request, genes=True)\n",
    "print(json.dumps(drug_dict_up, indent=4), '\\n')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "inhibitors = []\n",
    "for genes in sig_genes_up.values():\n",
    "    inhibitors.append(bf.dgidb_get_request(genes, interaction_types=['inhibitor']))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "UP-REGULATED INHIBITORS:\n",
      "\n",
      "{\n",
      "    \"Proteomics_Tumor_Normal_Other_tumor\": {\n",
      "        \"FTH1\": {\n",
      "            \"IRON DEXTRAN\": [\n",
      "                \"other\"\n",
      "            ]\n",
      "        },\n",
      "        \"GNLY\": {\n",
      "            \"MYELOPEROXIDASE\": []\n",
      "        },\n",
      "        \"MAP2K7\": {\n",
      "            \"COBIMETINIB\": [\n",
      "                \"allosteric modulator\",\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"Refametinib\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TRAMETINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AZD-8330\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"SELUMETINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PD-0325901\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DABRAFENIB MESYLATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"BINIMETINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"IODOACETAMIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"WX-554\": []\n",
      "        },\n",
      "        \"NPY\": {\n",
      "            \"HALOPERIDOL\": [],\n",
      "            \"ESTRADIOL BENZOATE\": [],\n",
      "            \"BROMOCRIPTINE\": [],\n",
      "            \"ETHER\": [],\n",
      "            \"ROSIGLITAZONE\": [],\n",
      "            \"K-252A\": [],\n",
      "            \"CHEMBL1230906\": []\n",
      "        }\n",
      "    },\n",
      "    \"Histologic_type_Serous\": {\n",
      "        \"ACTL6A\": {\n",
      "            \"CHEMBL225155\": [\n",
      "                \"agonist\"\n",
      "            ]\n",
      "        },\n",
      "        \"ARID1A\": {\n",
      "            \"TRASTUZUMAB\": [],\n",
      "            \"DASATINIB\": [],\n",
      "            \"CHEMBL3287735\": []\n",
      "        },\n",
      "        \"BCL2L1\": {\n",
      "            \"CHEMBL106708\": [],\n",
      "            \"NAVITOCLAX\": [\n",
      "                \"antagonist\",\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ISOSORBIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL376408\": [\n",
      "                \"antagonist\"\n",
      "            ],\n",
      "            \"VENETOCLAX\": [\n",
      "                \"antagonist\"\n",
      "            ],\n",
      "            \"OBATOCLAX MESYLATE\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"CAD\": {\n",
      "            \"ASPARTIC ACID\": [],\n",
      "            \"PALA\": []\n",
      "        },\n",
      "        \"CARM1\": {\n",
      "            \"CHEMBL468927\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PREGNENOLONE\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"CBS\": {\n",
      "            \"PYRIDOXAL PHOSPHATE\": [\n",
      "                \"cofactor\"\n",
      "            ],\n",
      "            \"S-ADENOSYL-L-METHIONINE\": [\n",
      "                \"activator\"\n",
      "            ],\n",
      "            \"SERINE\": [],\n",
      "            \"CYSTEINE\": [],\n",
      "            \"ARSENIC\": []\n",
      "        },\n",
      "        \"CD38\": {\n",
      "            \"DARATUMUMAB\": [\n",
      "                \"inhibitor\",\n",
      "                \"antibody\"\n",
      "            ],\n",
      "            \"ISATUXIMAB\": [\n",
      "                \"antibody\"\n",
      "            ],\n",
      "            \"THROMBIN\": [],\n",
      "            \"HuMax-CD38\": [],\n",
      "            \"SAR-650984\": []\n",
      "        },\n",
      "        \"CD40\": {\n",
      "            \"FLUDARABINE\": [],\n",
      "            \"HYDROQUINONE\": [],\n",
      "            \"STREPTOZOTOCIN\": [],\n",
      "            \"TETANUS TOXOID\": [],\n",
      "            \"DACETUZUMAB\": [\n",
      "                \"antibody\",\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PG-102\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LUCATUMUMAB\": [],\n",
      "            \"TENELIXIMAB\": [\n",
      "                \"partial agonist\"\n",
      "            ]\n",
      "        },\n",
      "        \"CDK11B\": {\n",
      "            \"AZD-5438\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PHA-793887\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"Roniciclib\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AT-7519\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"CDK12\": {\n",
      "            \"OLAPARIB\": [],\n",
      "            \"AZD-5438\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PHA-793887\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AT-7519\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"Roniciclib\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"CDKN2A\": {\n",
      "            \"PALBOCICLIB\": [],\n",
      "            \"LETROZOLE\": [],\n",
      "            \"Ribociclib\": [],\n",
      "            \"Roniciclib\": [],\n",
      "            \"ABEMACICLIB\": [],\n",
      "            \"ILORASERTIB\": [],\n",
      "            \"PANITUMUMAB\": [],\n",
      "            \"TRAMETINIB\": [],\n",
      "            \"GEMCITABINE\": [],\n",
      "            \"CHEMBL1231206\": [],\n",
      "            \"PF-00477736\": [],\n",
      "            \"GSK-461364\": [],\n",
      "            \"HMN-214\": [],\n",
      "            \"ALVOCIDIB\": [],\n",
      "            \"IMATINIB\": [],\n",
      "            \"CARBOPLATIN\": [],\n",
      "            \"PACLITAXEL\": [],\n",
      "            \"INK-128\": [],\n",
      "            \"ALECTINIB\": [],\n",
      "            \"CRIZOTINIB\": []\n",
      "        },\n",
      "        \"CIP2A\": {\n",
      "            \"GEMCITABINE\": []\n",
      "        },\n",
      "        \"CSNK2A1\": {\n",
      "            \"SILMITASERTIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL92361\": [],\n",
      "            \"CHEMBL270512\": [],\n",
      "            \"RESVERATROL\": [],\n",
      "            \"CHEMBL574060\": [],\n",
      "            \"BENZAMIDINE\": [],\n",
      "            \"CHEMBL572879\": [],\n",
      "            \"CHEMBL1230989\": [],\n",
      "            \"TETRABROMOBENZOTRIAZOLE\": [],\n",
      "            \"CHEMBL376505\": [],\n",
      "            \"CHEMBL222476\": [],\n",
      "            \"EMODIN\": [],\n",
      "            \"CHEMBL273101\": [],\n",
      "            \"CHEMBL404508\": [],\n",
      "            \"CHEMBL231095\": [],\n",
      "            \"CHEMBL389767\": [],\n",
      "            \"CHEMBL438303\": [],\n",
      "            \"CHEMBL230347\": [],\n",
      "            \"CHEMBL230137\": [],\n",
      "            \"CHEMBL230354\": [],\n",
      "            \"DICHLORORIBOBENZIMIDAZOLE\": [],\n",
      "            \"QUINALIZARIN\": [],\n",
      "            \"ELLAGIC ACID\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"HEPARIN\": []\n",
      "        },\n",
      "        \"DNMT3A\": {\n",
      "            \"AZACITIDINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DECITABINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DAUNORUBICIN\": [],\n",
      "            \"IDARUBICIN\": []\n",
      "        },\n",
      "        \"EHMT2\": {\n",
      "            \"CHEMBL569864\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL1231795\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL2441082\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"EIF2AK2\": {\n",
      "            \"CHEMBL1802728\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL235641\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"INTERFERON ALFA-2B\": []\n",
      "        },\n",
      "        \"ERBB2\": {\n",
      "            \"LAPATINIB\": [\n",
      "                \"antagonist\",\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PERTUZUMAB\": [\n",
      "                \"inhibitor\",\n",
      "                \"antibody\"\n",
      "            ],\n",
      "            \"TRASTUZUMAB\": [\n",
      "                \"inhibitor\",\n",
      "                \"antibody\"\n",
      "            ],\n",
      "            \"MARGETUXIMAB\": [\n",
      "                \"inhibitor\",\n",
      "                \"antibody\"\n",
      "            ],\n",
      "            \"ACALABRUTINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AEE-788\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AFATINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AC-480\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"BMS-690514\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CANERTINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CP-724714\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CUDC-101\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DACOMITINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"FALNIDAMOL\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"IBRUTINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MUBRITINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"NERATINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"Poziotinib\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"SAPITINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TESEVATINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"IGN-311\": [],\n",
      "            \"TRASTUZUMAB EMTANSINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"EVEROLIMUS\": [],\n",
      "            \"FULVESTRANT\": [],\n",
      "            \"PALBOCICLIB\": [],\n",
      "            \"TYRPHOSTIN AG 879\": [],\n",
      "            \"ANTHRAQUINONE\": [],\n",
      "            \"CHLORAMBUCIL\": [],\n",
      "            \"DEPSIPEPTIDE\": [],\n",
      "            \"DIETHYLSTILBESTROL\": [],\n",
      "            \"EMODIN\": [],\n",
      "            \"ETHYL NITROSOUREA\": [],\n",
      "            \"EPIRUBICIN\": [],\n",
      "            \"FILGRASTIM\": [],\n",
      "            \"FLOXURIDINE\": [],\n",
      "            \"ROMIDEPSIN\": [],\n",
      "            \"GEFITINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"GEMCITABINE\": [],\n",
      "            \"EPIGALOCATECHIN GALLATE\": [],\n",
      "            \"HYDROCORTISONE\": [],\n",
      "            \"PROXYPHYLLINE\": [],\n",
      "            \"ISOFLAVONE\": [],\n",
      "            \"MECHLORETHAMINE HYDROCHLORIDE\": [],\n",
      "            \"CHEMBL35482\": [],\n",
      "            \"VORINOSTAT\": [],\n",
      "            \"TAMOXIFEN\": [],\n",
      "            \"URACIL\": [],\n",
      "            \"VITAMIN E\": [],\n",
      "            \"CHEMBL2141478\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"SB-243213\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"INSM-18\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CIMAGLERMIN ALFA\": [],\n",
      "            \"Irbinitinib\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PELITINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"T-DM1\": [\n",
      "                \"antibody\"\n",
      "            ],\n",
      "            \"S-222611\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TAK-285\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LAPATINIB DITOSYLATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MOMELOTINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LITHOCHOLIC ACID\": [\n",
      "                \"antibody\"\n",
      "            ],\n",
      "            \"GANCICLOVIR\": [],\n",
      "            \"TIPIFARNIB\": [],\n",
      "            \"OSIMERTINIB\": [],\n",
      "            \"ROCILETINIB\": [],\n",
      "            \"MK-2206\": [],\n",
      "            \"ABEMACICLIB\": [],\n",
      "            \"LETROZOLE\": [],\n",
      "            \"ANASTROZOLE\": [],\n",
      "            \"EXEMESTANE\": [],\n",
      "            \"GONADORELIN\": [],\n",
      "            \"CRIZOTINIB\": [],\n",
      "            \"IRINOTECAN\": [],\n",
      "            \"DOCETAXEL\": [],\n",
      "            \"CAPECITABINE\": [],\n",
      "            \"PICTILISIB\": [],\n",
      "            \"CETUXIMAB\": [],\n",
      "            \"SIROLIMUS\": [],\n",
      "            \"PHENYLTHIOUREA\": [],\n",
      "            \"MM-302\": [],\n",
      "            \"PACLITAXEL\": [],\n",
      "            \"VARLITINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"VS-5584\": [],\n",
      "            \"PKI-179\": [],\n",
      "            \"ARQ-092\": [],\n",
      "            \"BUPARLISIB\": [],\n",
      "            \"BEVACIZUMAB\": [],\n",
      "            \"PONATINIB\": [],\n",
      "            \"SORAFENIB\": [],\n",
      "            \"Pyrotinib\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PA-799\": [],\n",
      "            \"TASELISIB\": [],\n",
      "            \"CUDC-907\": [],\n",
      "            \"IPATASERTIB\": [],\n",
      "            \"COPANLISIB\": [],\n",
      "            \"GEDATOLISIB\": [],\n",
      "            \"AZD-4547\": [],\n",
      "            \"FLUOROURACIL\": [],\n",
      "            \"LEUCOVORIN\": [],\n",
      "            \"OXALIPLATIN\": [],\n",
      "            \"AMG-337\": [],\n",
      "            \"BGB-283\": [],\n",
      "            \"TEMSIROLIMUS\": [],\n",
      "            \"DEPATUXIZUMAB MAFODOTIN\": [],\n",
      "            \"ERLOTINIB\": [],\n",
      "            \"PANITUMUMAB\": [],\n",
      "            \"SELUMETINIB\": [],\n",
      "            \"PILARALISIB (CHEMBL3218575)\": [],\n",
      "            \"CHEMBL1229592\": [],\n",
      "            \"CI-1040\": [],\n",
      "            \"CHEMBL392068\": [],\n",
      "            \"AT-13148\": [],\n",
      "            \"ENTINOSTAT\": [],\n",
      "            \"TRODUSQUEMINE\": [],\n",
      "            \"DOXORUBICIN\": [],\n",
      "            \"CYCLOPHOSPHAMIDE\": [],\n",
      "            \"SUNITINIB\": [],\n",
      "            \"METFORMIN\": [],\n",
      "            \"VINORELBINE BASE\": [],\n",
      "            \"TEGAFUR\": [],\n",
      "            \"LAPULEUCEL-T\": [],\n",
      "            \"RILOTUMUMAB\": [],\n",
      "            \"ONARTUZUMAB\": [],\n",
      "            \"OLAPARIB\": [],\n",
      "            \"SERIBANTUMAB\": [],\n",
      "            \"RAMUCIRUMAB\": [],\n",
      "            \"AZD-8055\": [],\n",
      "            \"BENZONATATE\": [],\n",
      "            \"TIVOZANIB\": [],\n",
      "            \"AFATINIB DIMALEATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"OSIMERTINIB MESYLATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"Allitinib\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"JNJ-26483327\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MP-412\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"Hemay-022\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CANERTINIB DIHYDROCHLORIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DACOMITINIB HYDRATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ERTUMAXOMAB\": [],\n",
      "            \"MDX-210\": [],\n",
      "            \"VANDETANIB\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"FADS1\": {\n",
      "            \"LINOLENIC ACID\": [\n",
      "                \"ligand\"\n",
      "            ],\n",
      "            \"ICOSAPENT\": [\n",
      "                \"agonist\"\n",
      "            ]\n",
      "        },\n",
      "        \"GANAB\": {\n",
      "            \"MIGLITOL\": [\n",
      "                \"antagonist\"\n",
      "            ]\n",
      "        },\n",
      "        \"GLDC\": {\n",
      "            \"PYRIDOXAL PHOSPHATE\": [\n",
      "                \"cofactor\"\n",
      "            ],\n",
      "            \"GLYCINE\": []\n",
      "        },\n",
      "        \"GMPS\": {\n",
      "            \"L-GLUTAMATE\": []\n",
      "        },\n",
      "        \"HCK\": {\n",
      "            \"BOSUTINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"IBRUTINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL1081312\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL306380\": [],\n",
      "            \"CHEMBL286939\": [],\n",
      "            \"QUERCETIN\": [],\n",
      "            \"DASATINIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ENMD-981693\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ILORASERTIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"XL-228\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TG100-801\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MASITINIB\": [],\n",
      "            \"NINTEDANIB\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"ILF3\": {\n",
      "            \"CYCLOSPORINE\": []\n",
      "        },\n",
      "        \"INHBA\": {\n",
      "            \"SOTATERCEPT\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"KDM2A\": {\n",
      "            \"CHEMBL2164243\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"KEAP1\": {\n",
      "            \"DIMETHYL FUMARATE\": [\n",
      "                \"inhibitor\",\n",
      "                \"binder\"\n",
      "            ],\n",
      "            \"BARDOXOLONE METHYL\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"KIF11\": {\n",
      "            \"CK0106023\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MONASTROL\": [],\n",
      "            \"CHEMBL205786\": [],\n",
      "            \"CHEMBL228369\": [],\n",
      "            \"CHEMBL481931\": [],\n",
      "            \"(R)-MON-97\": [],\n",
      "            \"CHEMBL205437\": [],\n",
      "            \"CHEMBL204459\": [],\n",
      "            \"CHEMBL380955\": [],\n",
      "            \"FILANESIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ISPINESIB (CHEMBL228814)\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LITRONESIB\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"KIF1A\": {\n",
      "            \"PHOSPHOMETHYLPHOSPHONIC ACID ADENYLATE ESTER\": [],\n",
      "            \"CHEMBL1230989\": []\n",
      "        },\n",
      "        \"KIF2C\": {\n",
      "            \"CHEMBL1230989\": []\n",
      "        },\n",
      "        \"KLC3\": {\n",
      "            \"PHENYLTHIOUREA\": [],\n",
      "            \"FLUOROURACIL\": [],\n",
      "            \"IFOSFAMIDE\": [],\n",
      "            \"OXALIPLATIN\": []\n",
      "        },\n",
      "        \"MED1\": {\n",
      "            \"BECOCALCIDIOL\": []\n",
      "        },\n",
      "        \"MSH2\": {\n",
      "            \"PEMBROLIZUMAB\": [],\n",
      "            \"NIVOLUMAB\": [],\n",
      "            \"IPILIMUMAB\": [],\n",
      "            \"ATEZOLIZUMAB\": [],\n",
      "            \"DURVALUMAB\": []\n",
      "        },\n",
      "        \"MSH6\": {\n",
      "            \"TEMOZOLOMIDE\": [],\n",
      "            \"PEMBROLIZUMAB\": [],\n",
      "            \"NIVOLUMAB\": [],\n",
      "            \"IPILIMUMAB\": [],\n",
      "            \"ATEZOLIZUMAB\": [],\n",
      "            \"DURVALUMAB\": []\n",
      "        },\n",
      "        \"MTHFD2\": {\n",
      "            \"TETRAHYDROFOLATE\": [\n",
      "                \"cofactor\"\n",
      "            ],\n",
      "            \"CHEMBL1161866\": []\n",
      "        },\n",
      "        \"MYO9B\": {\n",
      "            \"MANNOMUSTINE\": [],\n",
      "            \"CAFFEINE\": [],\n",
      "            \"CAPTOPRIL\": [],\n",
      "            \"DIBUCAINE\": [],\n",
      "            \"FELODIPINE\": [],\n",
      "            \"PROPYLTHIOURACIL\": [],\n",
      "            \"VOLANESORSEN SODIUM\": [],\n",
      "            \"STREPTOZOTOCIN\": [],\n",
      "            \"TESTOSTERONE\": [],\n",
      "            \"WORTMANNIN\": [],\n",
      "            \"NIFEDIPINE\": []\n",
      "        },\n",
      "        \"PAK2\": {\n",
      "            \"SELEGILINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"STAUROSPORINE\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"PARP1\": {\n",
      "            \"CHEMBL123904\": [],\n",
      "            \"NIACINAMIDE\": [\n",
      "                \"binder\"\n",
      "            ],\n",
      "            \"CHEMBL401843\": [],\n",
      "            \"CHEMBL123978\": [],\n",
      "            \"CHEMBL125200\": [],\n",
      "            \"CHEMBL134022\": [],\n",
      "            \"CHEMBL338790\": [],\n",
      "            \"VELIPARIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"CHEMBL452800\": [],\n",
      "            \"CHEMBL361054\": [],\n",
      "            \"OLAPARIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"RUCAPARIB\": [\n",
      "                \"inhibitor\",\n",
      "                \"antagonist\"\n",
      "            ],\n",
      "            \"NIRAPARIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"HEPTANOATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TALAZOPARIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"INOSINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"INIPARIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TALAZOPARIB TOSYLATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"RUCAPARIB CAMSYLATE\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"PDF\": {\n",
      "            \"CHEMBL431210\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"PRKCI\": {\n",
      "            \"CEP-2563\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"GF-109203\": [],\n",
      "            \"STAUROSPORINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"GSK-690693\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"(7S)-HYDROXYL-STAUROSPORINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"QUERCETIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MIDOSTAURIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"INGENOL MEBUTATE\": [],\n",
      "            \"SOTRASTAURIN\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"PRRC2A\": {\n",
      "            \"CARBAMAZEPINE\": []\n",
      "        },\n",
      "        \"SMARCA4\": {\n",
      "            \"TRETINOIN\": [],\n",
      "            \"VINORELBINE BASE\": []\n",
      "        },\n",
      "        \"SMARCA5\": {\n",
      "            \"DEXTROSE\": []\n",
      "        },\n",
      "        \"SMARCB1\": {\n",
      "            \"PANOBINOSTAT\": [],\n",
      "            \"PALBOCICLIB\": [],\n",
      "            \"ALVOCIDIB\": [],\n",
      "            \"FENRETINIDE\": [],\n",
      "            \"VORINOSTAT\": [],\n",
      "            \"PENTANAL\": []\n",
      "        },\n",
      "        \"STAT2\": {\n",
      "            \"ISOTRETINOIN\": []\n",
      "        },\n",
      "        \"THBS2\": {\n",
      "            \"CORTICOTROPIN\": [],\n",
      "            \"BEVACIZUMAB\": []\n",
      "        },\n",
      "        \"TK1\": {\n",
      "            \"THYMIDINE_TRIPHOSPHATE\": []\n",
      "        },\n",
      "        \"TNFSF10\": {\n",
      "            \"SODIUM BUTYRATE\": [],\n",
      "            \"TRICHOSTATIN\": []\n",
      "        },\n",
      "        \"TOP1\": {\n",
      "            \"CAMPTOTHECIN\": [],\n",
      "            \"EDOTECARIN\": [],\n",
      "            \"LUCANTHONE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ELSAMITRUCIN\": [],\n",
      "            \"7-ETHYL-10-HYDROXY-CAMPTOTHECIN\": [],\n",
      "            \"SODIUM STIBOGLUCONATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"KARENITECIN\": [],\n",
      "            \"CHEMBL343336\": [],\n",
      "            \"CAFFEINE\": [],\n",
      "            \"CYCLOPHOSPHAMIDE\": [],\n",
      "            \"BECATECARIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ETIRINOTECAN PEGOL\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"IRINOTECAN SUCROSOFATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LURTOTECAN\": [],\n",
      "            \"IRINOTECAN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TOPOTECAN\": [],\n",
      "            \"C-1311 (CHEMBL3545337)\": [],\n",
      "            \"RUBITECAN\": [],\n",
      "            \"IRINOTECAN HYDROCHLORIDE HYDRATE\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"TOP2A\": {\n",
      "            \"TENIPOSIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AMSACRINE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"VALRUBICIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"EPIRUBICIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ENOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PEFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"TROVAFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LOMEFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"NORFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LEVOFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"OFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"PODOFILOX\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MITOXANTRONE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"SPARFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DOXORUBICIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ETOPOSIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"GENISTEIN\": [],\n",
      "            \"FLEROXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"LUCANTHONE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"BANOXANTRONE\": [],\n",
      "            \"AMONAFIDE\": [],\n",
      "            \"ELSAMITRUCIN\": [],\n",
      "            \"BERUBICIN HYDROCHLORIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AMRUBICIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"FINAFLOXACIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DAUNORUBICIN\": [],\n",
      "            \"DEXRAZOXANE\": [],\n",
      "            \"HYDROQUINONE\": [],\n",
      "            \"VINCRISTINE\": [],\n",
      "            \"VOSAROXIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"AMRUBICIN HYDROCHLORIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ALDOXORUBICIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"BECATECARIN\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MM-302\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ETOPOSIDE PHOSPHATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DAUNORUBICIN CITRATE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DAUNORUBICIN HYDROCHLORIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DOXORUBICIN HYDROCHLORIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"MITOXANTRONE DIHYDROCHLORIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"IDARUBICIN\": [],\n",
      "            \"PACLITAXEL\": [],\n",
      "            \"C-1311 (CHEMBL3545337)\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"DACTINOMYCIN\": [],\n",
      "            \"CAMPTOTHECIN\": [],\n",
      "            \"IDARUBICIN HYDROCHLORIDE\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"IDRONOXIL\": []\n",
      "        },\n",
      "        \"TP53\": {\n",
      "            \"TARENFLURBIL\": [],\n",
      "            \"ASPIRIN\": [\n",
      "                \"acetylation\"\n",
      "            ],\n",
      "            \"Lesogaberan\": [],\n",
      "            \"CHEMBL1235116\": [],\n",
      "            \"DIETHYLSTILBESTROL\": [],\n",
      "            \"ENALAPRIL\": [],\n",
      "            \"RIZATRIPTAN\": [],\n",
      "            \"HALOPERIDOL\": [],\n",
      "            \"PROXYPHYLLINE\": [],\n",
      "            \"INOSITOL\": [],\n",
      "            \"INTERFERON ALFA-2B\": [],\n",
      "            \"CHEMBL1221512\": [],\n",
      "            \"METHIMAZOLE\": [],\n",
      "            \"METHYLPREDNISOLONE\": [],\n",
      "            \"MYCOPHENOLIC ACID\": [],\n",
      "            \"PACLITAXEL\": [],\n",
      "            \"PROPYLTHIOURACIL\": [],\n",
      "            \"PUROMYCIN\": [],\n",
      "            \"SIROLIMUS\": [],\n",
      "            \"RITUXIMAB\": [],\n",
      "            \"STREPTONIGRIN\": [],\n",
      "            \"TIRAPAZAMINE\": [],\n",
      "            \"THIOTEPA\": [],\n",
      "            \"TRIFLUOPERAZINE\": [],\n",
      "            \"URSODIOL\": [],\n",
      "            \"BEVACIZUMAB\": [],\n",
      "            \"VESNARINONE\": [],\n",
      "            \"YONDELIS\": [],\n",
      "            \"FLUOROURACIL\": [],\n",
      "            \"GARLIC\": [],\n",
      "            \"GOSSYPOL\": [],\n",
      "            \"GRANISETRON\": [],\n",
      "            \"ZINC CHLORIDE\": [],\n",
      "            \"BORTEZOMIB\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"ABEMACICLIB\": [],\n",
      "            \"AZD-6738\": [],\n",
      "            \"DECITABINE\": [],\n",
      "            \"DOXORUBICIN\": [],\n",
      "            \"GEMCITABINE\": [],\n",
      "            \"MITOMYCIN\": [],\n",
      "            \"AZD-1775\": [],\n",
      "            \"PRAMLINTIDE\": [],\n",
      "            \"DOCETAXEL\": [],\n",
      "            \"SELUMETINIB\": [],\n",
      "            \"TAMOXIFEN\": [],\n",
      "            \"OXALIPLATIN\": [],\n",
      "            \"CETUXIMAB\": [],\n",
      "            \"CAPECITABINE\": [],\n",
      "            \"CARBOPLATIN\": [],\n",
      "            \"GANETESPIB\": [],\n",
      "            \"SELICICLIB\": [],\n",
      "            \"Tepotinib\": [],\n",
      "            \"CRIZOTINIB\": [],\n",
      "            \"CYCLOPHOSPHAMIDE\": [],\n",
      "            \"TOPOTECAN\": [],\n",
      "            \"DASATINIB\": [],\n",
      "            \"DEMCIZUMAB\": [],\n",
      "            \"INK-128\": [],\n",
      "            \"PD-0325901\": [],\n",
      "            \"VX-970\": [],\n",
      "            \"EPIRUBICIN\": [],\n",
      "            \"GEDATOLISIB\": [],\n",
      "            \"ENCORAFENIB\": [],\n",
      "            \"NAVITOCLAX\": [],\n",
      "            \"DABRAFENIB\": [],\n",
      "            \"PF-04217903\": [],\n",
      "            \"DACTOLISIB\": [],\n",
      "            \"IRINOTECAN\": [],\n",
      "            \"CHEMBL376408\": [],\n",
      "            \"ALPELISIB\": [],\n",
      "            \"TRAMETINIB\": [],\n",
      "            \"CYTARABINE\": [],\n",
      "            \"NUTLIN-3\": [],\n",
      "            \"PAZOPANIB\": [],\n",
      "            \"VORINOSTAT\": [],\n",
      "            \"HEMICHOLINIUM-3\": [],\n",
      "            \"PF-00477736\": [],\n",
      "            \"PRODIGIOSIN\": [],\n",
      "            \"TRIFLURIDINE\": [],\n",
      "            \"RG-547\": [],\n",
      "            \"LY-3009120\": [],\n",
      "            \"VEMURAFENIB\": [],\n",
      "            \"DAUNORUBICIN\": [],\n",
      "            \"IFOSFAMIDE\": [],\n",
      "            \"DS-7423\": [],\n",
      "            \"LORLATINIB\": [],\n",
      "            \"SP-600125\": [],\n",
      "            \"PHA-680632\": [],\n",
      "            \"OLAPARIB\": [],\n",
      "            \"AZD-5363\": [],\n",
      "            \"CAPMATINIB\": [],\n",
      "            \"AMG-337\": [],\n",
      "            \"TANESPIMYCIN\": [],\n",
      "            \"PANITUMUMAB\": [],\n",
      "            \"AMG-900\": [],\n",
      "            \"AZD-6482\": [],\n",
      "            \"IBRUTINIB\": [],\n",
      "            \"ALVESPIMYCIN\": [],\n",
      "            \"PIMASERTIB\": [],\n",
      "            \"CHEMBL303958\": [],\n",
      "            \"TEMOZOLOMIDE\": [],\n",
      "            \"RG-7602\": [],\n",
      "            \"ETOPOSIDE\": [],\n",
      "            \"PEMBROLIZUMAB\": [],\n",
      "            \"DUVELISIB\": [],\n",
      "            \"AZD-7762\": [],\n",
      "            \"ERLOTINIB\": [],\n",
      "            \"CHEMBL392068\": []\n",
      "        },\n",
      "        \"TPX2\": {\n",
      "            \"N (g)-NITRO-L-ARGININE\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        },\n",
      "        \"TUBB4A\": {\n",
      "            \"EPOTHILONE D\": [],\n",
      "            \"PATUPILONE\": [],\n",
      "            \"LEXIBULIN\": []\n",
      "        },\n",
      "        \"VCAM1\": {\n",
      "            \"CARVEDILOL\": [\n",
      "                \"inhibitor\"\n",
      "            ],\n",
      "            \"SUCCINOBUCOL\": [],\n",
      "            \"DEXAMETHASONE\": [],\n",
      "            \"PHORBOL MYRISTATE ACETATE\": [],\n",
      "            \"TROGLITAZONE\": [],\n",
      "            \"MERCAPTOPURINE\": [],\n",
      "            \"CYCLOSPORINE\": []\n",
      "        },\n",
      "        \"WNT7A\": {\n",
      "            \"DIETHYLSTILBESTROL\": []\n",
      "        },\n",
      "        \"XPO1\": {\n",
      "            \"SELINEXOR\": [\n",
      "                \"inhibitor\"\n",
      "            ]\n",
      "        }\n",
      "    },\n",
      "    \"LVSI_1.0\": {\n",
      "        \"GLDC\": {\n",
      "            \"PYRIDOXAL PHOSPHATE\": [\n",
      "                \"cofactor\"\n",
      "            ],\n",
      "            \"GLYCINE\": []\n",
      "        },\n",
      "        \"HAPLN1\": {\n",
      "            \"HYALURONIC ACID\": [\n",
      "                \"binder\"\n",
      "            ]\n",
      "        },\n",
      "        \"PRRC2A\": {\n",
      "            \"CARBAMAZEPINE\": []\n",
      "        }\n",
      "    }\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "}\n"
     ]
    }
   ],
   "source": [
    "print('UP-REGULATED INHIBITORS:\\n')\n",
    "inhibitor_dict = {}\n",
    "for i, request in enumerate(requests_up):\n",
    "    clinical_attribute = sig_cols[i].columns[0][:-9]\n",
    "    inhibitor_dict[clinical_attribute] = bf.dgidb_json_parse(request, genes=True)\n",
    "print(json.dumps(inhibitor_dict, indent=4))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Step 7b: Compare patients' significant genes with the drugs they are currently taking"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['Patient_ID',\n",
       " 'Proteomics_Tumor_Normal',\n",
       " 'Country',\n",
       " 'Histologic_Grade_FIGO',\n",
       " 'Myometrial_invasion_Specify',\n",
       " 'Histologic_type',\n",
       " 'Treatment_naive',\n",
       " 'Tumor_purity',\n",
       " 'Path_Stage_Primary_Tumor-pT',\n",
       " 'Path_Stage_Reg_Lymph_Nodes-pN',\n",
       " 'Clin_Stage_Dist_Mets-cM',\n",
       " 'Path_Stage_Dist_Mets-pM',\n",
       " 'tumor_Stage-Pathological',\n",
       " 'FIGO_stage',\n",
       " 'LVSI',\n",
       " 'BMI',\n",
       " 'Age',\n",
       " 'Diabetes',\n",
       " 'Race',\n",
       " 'Ethnicity',\n",
       " 'Gender',\n",
       " 'Tumor_Site',\n",
       " 'Tumor_Site_Other',\n",
       " 'Tumor_Focality',\n",
       " 'Tumor_Size_cm',\n",
       " 'Num_full_term_pregnancies',\n",
       " 'MSI_status',\n",
       " 'Genomics_subtype']"
      ]
     },
     "execution_count": 51,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "list(clinical.columns)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "\"\\nThis cell is not working because I need to still connect the drugs that patients\\nare taking with the clinical dataframe somehow. I'll need to merge dataframes\\nmost likely.  Additionally, I will probably need to rework my function to include\\nan arg for medication_col_name or something like that to work on multiple datasets\\nand not just for Renal\\n\""
      ]
     },
     "execution_count": 52,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "'''\n",
    "This cell is not working because I need to still connect the drugs that patients\n",
    "are taking with the clinical dataframe somehow. I'll need to merge dataframes\n",
    "most likely.  Additionally, I will probably need to rework my function to include\n",
    "an arg for medication_col_name or something like that to work on multiple datasets\n",
    "and not just for Renal\n",
    "'''\n",
    "#patient_drugs_genes_up = bf.compare_enrichments_with_drugs(outlier_up_prot_dict, clinical)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "follow_up_df = pd.read_excel('CPTAC3_Uterine_FollowUp_Outcome_8_12.xlsx')"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.6.2"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
